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Abstract
To paraphrase Stan Ulam, a Polish mathematician who became a leading figure in the
Manhattan Project, in this dissertation I focus not only on how computer science can help
biologists, but also on how biology can inspire computer scientists.
On one hand, computer science provides powerful abstraction tools for metabolic
networks. Cell metabolism is the set of chemical reactions taking place in a cell, with
the aim of maintaining the living state of the cell. Due to the intrinsic complexity of
metabolic networks, predicting the phenotypic traits resulting from a given genotype and
metabolic structure is a challenging task. To this end, mathematical models of metabolic
networks, called genome-scale metabolic models, contain all known metabolic reactions in
an organism and can be analyzed with computational methods. In this dissertation, I propose
a set of methods to investigate models of metabolic networks. These include multi-objective
optimization, sensitivity, robustness and identifiability analysis, and are applied to a set of
genome-scale models.
Then, I augment the framework to predict metabolic adaptation to a changing envi-
ronment. The adaptation of a microorganism to new environmental conditions involves
shifts in its biochemical network and in the gene expression level. However, gene ex-
pression profiles do not provide a comprehensive understanding of the cellular behavior.
Examples are the cases in which similar profiles may cause different phenotypic outcomes,
while different profiles may give rise to similar behaviors. In fact, my idea is to study
the metabolic response to diverse environmental conditions by predicting and analyzing
changes in the internal molecular environment and in the underlying multi-omic networks.
I also adapt statistical and mathematical methods (including principal component analysis
and hypervolume) to evaluate short term metabolic evolution and perform comparative
analysis of metabolic conditions.
On the other hand, my vision is that a biomolecular system can be cast as a “biological
computer”, therefore providing insights into computational processes. I therefore study
how computation can be performed in a biological system by proposing a map between
a biological organism and the von Neumann architecture, where metabolism executes
reactions mapped to instructions of a Turing machine. A Boolean string represents the
genetic knockout strategy and also the executable program stored in the “memory” of the
organism. I use this framework to investigate scenarios of communication among cells,
gene duplication, and lateral gene transfer. Remarkably, this mapping allows estimating the
computational capability of an organism, taking into account also transmission events and
communication outcomes.
v
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Chapter 1
Introduction
Understanding the role of individual components in a biological system is an important
step to elucidate or predict its behavior. However, a major theme in the discipline called
systems biology is investigating these systems with an integrated approach. In fact, studying
the interactions between different components also gives insights into the functioning and
behavior of the components taken independently [90].
1.1 Systems biology and metabolic networks
In systems biology, the value of modelling a biological system is not merely explanatory of
a biological process, but also predictive. A model can be used to suggest hypotheses that
can be tested, or to pinpoint unexpected behaviors that can be further investigated in vitro.
Systems biology was pioneered by Tomita et al. [161], who provided the first quantitative
model for the simulation of a full cell metabolism. More recently, a research effort by Karr
et al. [85] provided, for the first time, a whole-cell computational model of the life cycle of
a small pathogenic bacterium, Mycoplasma genitalium. The model includes metabolism,
replication of the genome, and cell division.
The term metabolism refers to the set of chemical reactions taking place in living cells,
with the aim of maintaining cellular functions. Once considered only a passive result of the
state of a cell, metabolism is now widely recognized as a main contributor to the cell behav-
ior. In the last 25 years, high-quality genome-scale models (also called reconstructions)
of metabolic networks have been combined with constraint-based optimization in order to
analyze microorganisms at steady state. On one hand, metabolic reconstructions of bacteria
have been developed to facilitate the study and manipulation of biochemical processes [124],
allowing the bio-production of valuable compounds to be optimized through metabolic en-
gineering [89]. On the other hand, the study of human metabolism is becoming increasingly
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important for biomedical applications as an approach for understanding many diseases and
aspects of health. This is enabled by the availability of high-quality reconstructions such as
Recon2 [159], which integrates extensive metabolic information from various resources.
Systems-based approaches have been successfully applied over the last decade to
investigate metabolic networks, composed of a set of chemical reactions and a pool of
metabolites (both reactants and products of the chemical reactions). There are different
methods to represent a metabolic system, for instance by using a set of linear equations
or ordinary differential equations (ODEs). Each variable represents the variation of a
metabolite concentration, in a dynamic or steady state, where the metabolite concentration
depends on the rates of the reactions that produce and consume that metabolite. Each flux
can also be modeled by using kinetic parameters [87]. However, ODE-based systems often
contain a large number of equations (differential or algebraic), and solving the problem
analytically is often very hard. This bottleneck recently led to the increasing use of steady-
state models analyzed with linear methods. Flux balance analysis (FBA) is the most widely
used method of this class.
FBA is in fact the most widely used constraint-based technique to predict flux distribu-
tions and network capabilities in large biochemical networks [24]. FBA has proved useful
thanks to its ability to handle large networks: it requires information about biochemical re-
actions and stoichiometric coefficients, but does not involve kinetic parameters. This makes
it well suited to studies that enumerate and characterize perturbations such as different
substrates or genetic interventions (e.g., knockouts) leading to obligatory coupling between
the growth rate and the overproduction of a desired metabolite [167]. In general, FBA is a
very powerful tool for predictions of cell behavior under different metabolic conditions.
More specifically, FBA is a linear programming technique that models the steady-state
condition in a chemical reaction network (see Section 1.2) [120]. The combination of
flux balance constraints and capacity constraints on reaction fluxes is a system of linear
homogeneous equations and inequalities; thus, its solution space is a convex polyhedral
cone representing the feasible flux distributions. Intuitively, the steady-state constraints used
in FBA can be thought of as Kirchoff’s laws applied to any node representing a metabolite
in the network: the flux through each metabolite in the network must be constant, namely
the input flux must equal the output flux.
Although FBA provides a steady-state representation of metabolism, as biologists would
agree, there is no biology except in the light of evolution [55]. Much of the uncertainty
about the behavior of a microorganism is due to the lack of statistical bioinformatics
methodologies for accurate measure of adaptability to different environmental conditions
and over time [65, 137]. Approaches involving both mathematics and bioinformatics would
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benefit from the study of the molecular response to adaptation. In turn, this would enable
to discover the relation between environmental (“external”) conditions and changes in the
metabolic-phenotypic networks (the “internal” environment). At the same time, it would
elucidate the genotype-phenotype relationship, which is still an open problem in biology.
As a result of many recent research efforts to elucidate the relation between genotype
and phenotype, we currently have models for a better understanding of the individual
components, but arguably a less clear picture of the interactions between the biological com-
ponents that result in a given phenotype [24]. We still have, moreover, limited knowledge
about how to use these models to predict a phenotypic response to a changing environmental
condition, due to the lack of comprehensive data across different conditions and accurate
training processes performed on the models [35].
Measurements of gene expression level are able to generate transcriptional profiles of
microorganisms across a diverse set of environmental conditions. Databases of environmen-
tal conditions have been recently produced for several organisms, including Escherichia coli
[58], Clostridium [98], Salmonella [80], and fission yeast [96]. Although such resources,
coupled with statistical analysis, remain key to the interpretation of measured data, they do
not provide a comprehensive understanding of the resulting cellular behavior. For instance,
similar gene expression profiles may cause different phenotypic outcomes, while different
environmental conditions may give rise to similar behaviors. Additionally, the actual re-
sponse to a given condition is highly dependent on the multiple cellular objectives that the
microorganism is required to meet [13, 63].
In particular, modifications of FBA are able to reduce the problem of determining the
metabotype (the fluxes through all reactions in the system) under a given condition and
gene expression profile to a tractable linear program under the assumptions of steady-state
and optimality. Due to their scalability and precision, these methods have been used widely,
for example to predict growth phenotypes in specific environmental conditions [139].
The overall functioning of an organism due to changes in the environmental condition
affects various levels of cellular organization. Complex alterations involve also gene
expression and metabolism [92]. In both metabolic engineering and disease studies we
often seek the gene expression profiles that could lead to some desired metabolic state. This
amounts to solving the inverse problem of what is typically addressed through FBA, but
computational methods suitable for such studies are still lacking [154].
In this dissertation, we propose a set of methods to analyze and optimize genome-scale
metabolic models. The recent availability of high-throughput data regarding multiple layers
of biological organization (called omics) allows mapping cellular processes at the levels of
mRNA, proteins, and metabolites. The aim of this dissertation is also to propose methods
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aimed at improving the predicting capability of a metabolic model and elucidating the
genotype-phenotype relationship by including multiple biological layers in the model. We
specifically focus on gene expression and codon usage.
Genome-scale models. Genome-scale metabolic models contain all known metabolic
reactions in an organism. A genome-scale model, which represents the starting point for
FBA, is built using the following process. First, a draft reconstruction is obtained using
annotated enzyme, reaction and pathway data from databases like KEGG [84] and EcoCyc
[86]. Details on which genes control each reaction are also included. Then, a literature
review improves the draft reconstruction. At this stage, the FBA representation of the model
is built. Finally, the model is run and validated by comparing its predictions with existing
experimental results, and new experiments are performed to further improve and validate
the model.
1.2 Flux balance analysis
A central role in systems biology is played by mathematical models, possibly allowing
for a comprehensive analysis of complex biological systems. The idea of flux balance
analysis (FBA) is to start from a system of ODEs – one for each chemical in the system –
and then supposing a steady state. This assumption enables the use of linear systems and
linear programming. As well as permitting the simulation of large, usually genome-scale,
systems in a few seconds of CPU time, this approximation has the additional advantage of
facilitating the introduction of additional layers of experimental data that can be added to
the model. These layers, e.g., proteome, fluxome or transcriptome data, are usually referred
to as omics (this topic will be extensively covered in Chapter 3).
FBA is widely used in systems biology to quantify the entire metabolic steady-state of a
cell and calculate its flux distribution. In FBA, all known metabolic reactions in a given cell
are considered, and they are mathematically described in a way that allows simulation of
various states and configurations of the chemical reaction network.
As introduced above, FBA is based on two main assumptions:
• Homeostatic assumption: the organism has reached a steady state where the metabo-
lite concentrations are constant and a set of nutrients are being constantly converted
to generate biomass;
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• (Multi-level) optimality: in each state, the organism tends to maximize one or
multiple objectives, usually related to growth, biotechnologically-relevant compounds
(e.g., acetate exchange) and important energy-carrying molecules (e.g., ATP).
FBA is usually applied to genome-scale models, built as described in Section 1.1.
From the beginning, FBA was widely used for metabolic engineering of microorganisms
to enhance the production of biotechnologically or industrially relevant chemicals. Re-
cently, predictions of flux distributions, combined with experimental methods, have been
successfully used to formulate novel biological hypotheses. For instance, FBA has been
used to generate tissue-specific models of human metabolism [118], and to identify novel
therapeutic targets against infections [98].
1.2.1 Mathematical formulation of FBA
FBA is suitable for analyzing the flow of metabolites through a metabolic network (e.g.,
their formation and degradation, transport and cellular utilization). Mathematically, in a
metabolic network, the derivative of a metabolite concentration can be computed through
a linear combination of the input and output reaction fluxes, which produce and consume
(respectively) that metabolite. Let the network be composed of m metabolites with con-
centration xi, i = 1, . . . ,m and n reactions with flux rates v j, j = 1, . . . ,n. The balance that
metabolite concentrations xi must satisfy is
dxi
dt
=
n
∑
j=1
Si jv j, i = 1, . . . ,m, (1.1)
where Si j is the stoichiometric coefficient of the ith metabolite in the jth reaction. A negative
(positive) coefficient Si j in the stoichiometric matrix indicates that the ith metabolite is
consumed (produced) in the jth reaction. A metabolite that is not part of the reaction, has a
zero entry for the corresponding column. Since each metabolite is part of a very limited
number of reactions in the network, S is a sparse matrix.
Under steady state conditions dxidt = 0, ∀i, the balance for the ith metabolite is∑nj=1 Si jv j =
0 (homeostatic assumption). Therefore, at steady state, the balance equation is Sv = 0,
where S is the stoichiometric matrix (m rows and n columns), and v is the vector of the flux
rates (metabolic and transport fluxes).
In a metabolic network, metabolites/nodes are linked by reactions/edges. In FBA each
node (i.e., metabolite) of the metabolic network represents a constraint, while the reaction
rates v j represent the variables. Since the matrix S is not square and n > m, we have
more variables than constraints, and therefore a plurality of solutions. Each solution is a
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S·v = 0 
S·v = 0 
v ≥ 0  
S·v = 0 
v ≥ 0 
v ≤ vMAX  
Stoichiometry (S) S + Irreversibility (I) S + I + Capacity (C) 
Rn-m ⊂ Rn  
Rn  
Convex polyhedral cone Convex polytope 
Maximize fT·v s.t.: 
S·v = 0 
v ≥ 0 
v ≤ vMAX  
Linear program 
Vertex of the polytope 
Fig. 1.1 Mathematical formulation of flux balance analysis. The stoichiometric matrix
S of n reactions and m metabolites restricts the search of possible flux distributions to the
hyperplane Rn−m. Thermodynamic constraints (irreversibility of reactions) limit the space
of feasible solutions, which becomes a polyhedral cone. Capacity constraints (enzyme or
transport capacities) constitute an upper bound for the flux rates. If this is available for every
flux in the network (more specifically, it is sufficient that the upper bound is available for
the edges of the cone), the feasible space reduces to a convex polytope. Once an objective
function has been defined, the final linear program finds the final flux distribution as a vertex
of the convex polytope, and then reconstructs the solution in the initial space Rn.
distribution of fluxes v and represents a particular metabolic steady state. The FBA approach
seeks the metabolic state that optimizes a linear combination of flux rates, considered as
objective functions (optimality assumption):
maximize (or minimize) f ᵀv,
such that Sv = 0,
vLj ≤ v j ≤ vUj , j = 1, . . . ,n,
(1.2)
where f is a n-dimensional column vector of weights, and f ᵀ is its transpose. There may be
more than one element in f equal to 1, when there are several flux rates to optimize; this is
equivalent to optimizing a linear combination of them. The bounds vLj and v
U
j are the lower
and upper bound values for the flux v j, and represent thermodynamic constraints. In our
analysis, we consider vUj = 1000 and v
L
j =−1000 for the fluxes of reversible reactions, and
vUj = 1000 and v
L
j = 0 for the fluxes of irreversible reactions.
As shown in Fig. 1.1, the constraints in FBA consist of a set of linear equations
representing flux balance constraints, plus a set of inequalities representing thermodynamic
and enzyme capacity constraints. The system is solved using linear programming. This
homogeneous system of m equations and n variables is usually highly underdetermined,
since the number of reactions is greater than the rank of the stoichiometric matrix, unless
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the value of some reaction fluxes is already known [91, 101]. The null space matrix V
is defined as the matrix whose columns constitute a complete set of linearly independent
solutions of Sv = 0. Since every linear combination of solutions of Sv = 0 is also a solution,
the columns of V span the kernel (null space) of S.
The output of FBA is a particular distribution of fluxes, denoted by v∈Rn, that optimizes
the objective functions. We remark that FBA does not describe how a certain flux distribution
is obtained (by kinetics or enzyme regulation), but finds which flux distribution is optimal
for the organism when the maximization of specific objectives is required.
1.2.2 Selection of FBA objectives
The selection of a reaction flux as an objective to maximize in FBA is done through the
vector f in (1.2). The most commonly chosen is the metabolic reaction representing biomass
formation, which is scaled to represent the exponential growth rate of the bacterial culture.
This choice is motivated by the assumption that cells maximize the growth rate as a priority,
to ensure survival. The biomass reaction is often used also as an indicator of the role of any
other reaction in the model. For instance, the impact of a gene knockout, which may result
in a reaction turned off, is measured through the change of flux rate of the biomass reaction.
Unless otherwise stated, we will consider the biomass as the first objective in every
analysis performed on genome-scale models. However, biomass is not the only objective
considered in FBA. The maximization of ATP, a coenzyme used as an energy source in the
cell, is also common. In metabolic engineering, the interest is towards the overproduction
of a “synthetic” objective, e.g., acetate or succinate exchange flux, or even a nonnative
metabolite such as 1,4-butanediol, with nonnative pathways added to the chemical reaction
network [177].
1.2.3 Limitations of FBA
FBA has its shortcomings. First, an ideal model should include different biological processes
at different scales (e.g., transcription, translation, signaling, and metabolism). Therefore,
modeling the metabolism on its own using FBA ignores the remaining processes and their
regulation of cellular function. Furthermore, kinetic ODE models are more suitable than
FBA when the focus is on modeling regulatory mechanisms or metabolite concentrations.
However, techniques based on ODEs are suitable only for small subsystems where experi-
mental data is available, and do not scale well for large or genome-scale system due to the
high computational cost and to the large number of parameters that need to be estimated.
There is also little availability of kinetic data for the simulation of chemical reaction net-
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works. These issues significantly limit the ability to study genome-scale systems using an
ODE-based approach.
A further challenge in metabolic modeling is the combination of extracellular dynamics
and intracellular steady state. FBA is a steady-state analysis and therefore does not natively
support dynamics. To approximate metabolic behavior under dynamic conditions, a step-
wise FBA, called “Dynamic FBA” was introduced (see Section 1.3.1). As the focus of
the present work is to analyze large genome-scale metabolic models with a systems-based
approach, throughout this dissertation the FBA steady-state approach will be used.
1.3 Applications and challenges of flux balance analysis
Recently, more than 1000 prokaryotic genomes have been fully sequenced, thus allowing
FBA models to incorporate also information on enzymes and genome, including the re-
lationships among genes, proteins and reactions (GPR mapping). To date, more than 90
genome-wide metabolic reconstructions have been published [39]. FBA-based approaches
have proved more efficient than other mathematical modeling techniques, such as those
based on ordinary differential equations, at tackling genome-scale metabolic networks [47].
As a result, they have been extensively used to characterize energy production in cells [8],
and to design synthetic pathways in silico (e.g., for the production of biofuels [177]). The
main toolbox for performing FBA in MATLAB is the COBRA toolbox by Palsson’s group
[143].
1.3.1 Dynamic FBA
In order to combine extracellular dynamics and intracellular steady states, and therefore
model metabolism under dynamic conditions, a step-wise FBA approach, commonly re-
ferred to as Dynamic FBA, has been developed [104]. The idea is that a steady-state FBA
simulation is performed at each time step, and the uptake rates of given nutrients for the
next simulation are reduced according to how much nutrient has been consumed in the
previous FBA simulation.
More specifically, the assumption is that the bacterium has a limited availability of
extracellular nutrients (e.g., glucose), encoded as a constraint (maximum uptake rate) in the
associated exchange reaction. Then, after an FBA simulation is run, the amount of nutrient
which has been actually taken up by the organism is used to reduce the nutrient availability
(maximum uptake rate) for the FBA simulation at the next time step.
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Dynamic FBA allows investigating genome-scale networks under transient conditions.
It can be thought of as a compromise between fully dynamic models, which cannot be
simulated at large scale, and steady-state models, which do not involve kinetics.
1.3.2 Regulatory FBA
Regulatory FBA, proposed by Covert et al. [46], is a framework where the regulatory
mechanisms affecting genes are used in conjunction with FBA. Since genes control reactions
in the genome-scale model, the presence of an enzyme or regulatory protein may cause
given genes to be inactive. Therefore, the corresponding reaction is temporarily removed
from the model (e.g., by constraining its lower and upper bounds to be 0). Similarly to
Dynamic FBA, the regulatory constraints and the uptake flux bounds are updated in a
step-wise manner to allow dynamic modelling of growth. While this approach provides an
effective way of modelling regulatory or gene expression-based constraints on FBA models,
only Boolean regulation of reactions (on/off) is allowed.
1.3.3 MONGOOSE: solving FBA using exact rational arithmetic
As mentioned above, COBRA [143] is arguably the most widely used toolbox for FBA.
Chindelevitch and co-workers recently developed MONGOOSE [39], a pipeline to per-
form structural analysis and reduction of a genome-scale metabolic network using exact
arithmetic (rational instead of floating point). The main claim of MONGOOSE is that,
when using exact arithmetic, the biomass reaction is blocked (i.e., not able to carry any flux
under any condition) in 44 out of the 89 models examined. Remarkably, they claim that
the biomass of three out of ten curated models in the BiGG database from Palsson’s group
[142] were reported as blocked by MONGOOSE but not by COBRA 1.
Since MONGOOSE was released, an interesting debate has grown in the metabolic
modeling community. This was mainly due to the strong claim that those three models
curated by Palsson’s group (Escherichia coli iAF1260, Helicobacter pylori iIT341 and
Mycobacterium tuberculosis iNJ661), were able to carry a nonzero biomass using COBRA’s
floating point operations, but were blocked to zero biomass if using exact arithmetic in
MONGOOSE. In the original MONGOOSE paper, the authors claimed that this difference
was due to “COBRA not enforcing the flux balance constraints on internal metabolites
exactly” (i.e., using rational arithmetic). The proposed explanation was that, even if the
deviations from exact flux balance are small, they can make the difference between a
feasible and an unfeasible problem.
1The MONGOOSE name is indeed referred to the fact that the mongooses are able to fight and kill cobras.
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However, after a commentary by Palsson’s group [40], Chindelevith at al. revisited
their claim in a recent commentary [114]. In fact, the claim on the three BiGG models
being blocked was incorrect, and was due to an incorrect parsing (for two of them) and to a
MONGOOSE bug (for the third model). The blockage of five additional models was also
due to different parsing between COBRA and MONGOOSE. Although the MONGOOSE
bug is reported as a “minor bug”, it affects the biomass coefficients and occasionally other
coefficients; as a result, four additional models previously classified as blocked were indeed
working correctly. Therefore, the original MONGOOSE claims and the initial claim of
strong discrepancies between MONGOOSE and COBRA have been significantly weakened.
1.3.4 Incorporating transcriptomic data in FBA models
The integration of various levels of biological organization (omics) in FBA models enables
the generation of better computational models with improved predictive capabilities. For in-
stance, the transcriptomic level consists of gene expression levels quantifying the amount of
mRNA concentration found in a cell after transcription of genes from the DNA. The mRNA
is then translated to proteins, which directly affect the rate at which a chemical reaction
takes place in the metabolism. The idea underlying gene expression-based approaches in
FBA is therefore that the amount of mRNA, which indicates the expression of a given gene,
can serve as an indicator of the protein abundance, and consequently of the activity of the
corresponding reactions in the metabolism.
Methods for integrating transcriptomic data in genome-scale metabolic models have
been recently reviewed and evaluated [88, 103]. They can be divided into two subsets:
discrete methods and continuous methods. Discrete methods perform binarization (or
discretization if more than two levels are used) of gene expression levels in order to set
the active and inactive states of the corresponding reactions. The most common approach
consists of turning off a reaction if the corresponding gene expression level is below a given
threshold. The first on/off techniques were proposed by Covert et al. [46] and Åkesson
et al. [2]; similar techniques were then proposed: GIMME [20], iMAT [184] (which uses
tri-valued “low/mid/high” expression states), PROM [36], MADE [81], and EXAMO [138].
The main drawback of these methods is the introduction of a threshold that needs to be
determined. Additionally, small changes in gene expression level are not captured (unless
they cross the threshold level) and therefore different gene expression profiles may yield
identical metabolic outcomes.
Continuous methods are instead based on a real-valued map linking gene expression
levels and flux bounds of the corresponding reactions. The map is difficult to determine, as
the problem of finding a genotype-to-phenotype map is still unsolved in biology. However,
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this approach ensures full control on the constraints of the linear program, and even slight
modifications in the gene expression level are captured and mapped to the metabolic model,
yielding a different metabolic state. Methods belonging to this category are: E-Flux [42]
(reactions controlled by overexpressed genes have weaker constraints for their flux rates),
Lee et al. [99] (transcriptomic data incorporated in the objective function), and FALCON
[18].
Whether gene expression only is a good estimate for protein abundance is still a matter
of debate. Therefore, relying solely on transcriptomic data to estimate flux rates in a
metabolic network has its disadvantages. For instance, degradation rates, post-translational
modifications, protein regulation and degradation are all involved in the biological steps
between gene activity and reaction activity, but they are not taken into account by these
approaches.
In Chapter 3, FBA is extended to account for environmental conditions by incorporating
gene expression levels (transcriptomic) into the model with a continuous approach. Once
gene expression has been mapped to the metabolic network, gene expression levels become
variables of an optimization algorithm, and multi-objective optimization is performed.
Towards addressing the lack of intermediate steps modelled between gene expression and
protein abundance, we extend our method with codon usage information, which modifies the
translation of mRNA into proteins. Applying multi-objective optimization to the improved
model allows us to estimate the gene expression profiles that are likely to maximize the
growth rate of the cell while ensuring an optimal amount of an additional flux rate.
In this dissertation, we link the gene expression profiles with the FBA fluxes of the
associated reactions in E. coli defining a real-valued adjustable map. Protein synthesis is
an outcome of the expression of genes coding for protein segments. Hence, we link the
gene expression values to the flux of the reactions controlled by the proteins coded by those
genes. The approach adopted here, namely using the gene expression level as a proxy for
protein abundance, is supported by recent evidences on the correlation between mRNA
and protein levels [49, 71, 108]. More recently, Li et al. [100] and Jovanovic et al. [82]
showed that mRNA levels are the main contributors to the overall protein expression level in
mammals. We note that the availability of proteomic data, compared to gene expression data
only, would give direct information on the reaction rates, and would allow a more precise
definition of the constraints in the FBA model. However, while being more informative in
light of a metabolic model, protein concentration can be currently measured with a lower
precision and higher cost if compared to mRNA measurements.
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1.4 Multi-objective optimization: Pareto fronts in genome-
scale models
When a bacterial metabolic network needs to perform tasks that are in conflict with each
other, a multi-objective optimization algorithm is a useful tool to seek trade-off solutions.
The aim of multi-objective optimization in biological models is to optimize the secretion or
uptake of a set of target metabolites. The two or more contrasting goals of a multi-objective
algorithm are usually referred to as objective functions. The Pareto front, obtained as a
result of the multi-objective optimization pipeline, is defined as the set of points x such that
there does not exist any other point dominating x at all tasks (objective functions).
Let f1, ..., fr be the r objective functions that the organisms aims at optimizing simul-
taneously. Optimizing simultaneously means, formally, that the organism would need to
maximize the following vector function:
f (x) = ( f1(x), f2(x), ..., fr(x)),
x ∈multidimensional search space,
f (x) ∈multidimensional objective space,
(1.3)
where x is the variable (vector) to be optimized in the search space, and f (x) is the
corresponding vector in the objective space. Without loss of generality, we assume that all
functions have to be maximized, since minimizing a function fi is equivalent to maximizing
− fi.
The output of a multi-objective routine is a set of points in the objective space. This
set constitutes the Pareto front. It is achieved through the search for all the Pareto optimal
vectors x∗, namely all those x∗ in the search space for which
@ x ∈multidimensional search space s.t. [ fi(x)> fi(x∗),∀i = 1, ...,r] (1.4)
(or fi(x)< fi(x∗),∀i= 1, ...,r, for the minimization problem). When the objective functions
fi in the organism are in conflict with each other, the term optimizing can be thought of as
seeking trade-off solutions [41]. In computational biology, the Pareto front can be defined
as the set of all the phenotypes that remain after eliminating all the feasible phenotypes
dominated in all the tasks required [149].
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The Pareto front can be approximated using an evolutionary procedure called genetic
algorithm (GA). In this dissertation, we propose a genetic algorithm inspired by NSGA-II
[52] that performs the search in the space of (input) decision variables, namely Boolean
gene knockouts in Chapter 2, and continuous gene expression levels in Chapter 3. In a
multi-objective optimization problem, an evolutionary algorithm ensures low computational
cost and is able to generate a set of solutions in a single run.
A GA is a robust technique based on the principles of evolution and natural selection.
The main features of genetic algorithms are the crossover and mutation operators, which
allow the evolution process of the decision variables (inputs) to reach the global optimum
for the objective functions (outputs).
The GA is applied to an initial set of input arrays (also called individuals) representing
possible solutions to the problem. Initially, all individuals are ranked according to their non-
domination level (fitness or rank), which is based on the values of the objective functions
computed for each individual. After computing the fitness score for all the individuals of
the initial population, we employ a binary tournament selection, where two individuals are
selected at random, and their fitness is compared. The individual with the best fitness is
selected as a parent for the next population.
The algorithm then selects a number of parents (i.e., best individuals) equal to half of
the population. Parents are mutated using a combinatorial mutation and cross-over operator
to create an offspring, which joins the selected parents in a new population. Finally, the
whole process is repeated. As illustrated in Fig. 1.2, the idea behind the GA is that new
and possibly better individuals can be obtained by mutating and combining successful
existing individuals, and finally keeping only the best individuals with respect to two or
more competing objective functions.
Optimizing all the selected objectives simultaneously has advantages over reducing
the multi-objective problem to a single-objective optimization. Summarizing two or more
objectives in a single objective (e.g., using a linear combination of the objectives) needs
a correct estimation of the weights attributed to each objective (coefficients of the linear
combination), and most importantly does not permit to correctly approximate non-convex
Pareto fronts.
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Fig. 1.2 Genetic algorithms to approximate the Pareto front. Inspired by the principles
of evolution, a genetic algorithm starts from a pool of individuals and evaluates the cor-
responding output ( f1, f2) through the model (white front). Only the best individuals are
kept in the population and are used to generate new individuals (offspring) through point
mutation or cross-over of existing individuals (parents). This process is repeated until no
further improvement is detected on the Pareto front (red front in the figure).
1.6 Metabolic engineering
A comprehensive in silico analysis is the first step for designing a new synthetic organism.
Among the techniques for designing organisms in silico, metabolic engineering consists of
optimizing genetic and regulatory processes within cells to increase the cell production of
certain substances.
1.6.1 Metabolic engineering in genome-scale models: the problem of
a large search space
Arguably, Escherichia coli is the most extensively studied organism in biology, both in vitro
(synthetic biology) and in silico (metabolic engineering). In 2000, Edwards and Palsson [57]
published the first genome-scale metabolic network of the K12-MG1655 E. coli, composed
of 627 reactions, 438 metabolites and 660 genes. Then, the genome-scale reconstruction
of E. coli was updated to account for 904 genes, 625 metabolites and 931 reactions [133],
then 1260 genes, 1039 metabolites and 2077 reactions [60], and finally 1366 genes, 1136
metabolites and 2251 reactions [119].
Metabolic engineering has been applied to E. coli and other organisms to find the genetic
manipulations, namely gene knockouts, that enable overproduction of a given chemical
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(“synthetic” objective) in the metabolic network, while keeping a large rate of production
of biomass (“natural” objective). We remark that, because of the large number of genes
and reactions in the cellular metabolism, the size of the search space is enormous. For
instance, in the most recent model of E. coli (1366 genes), if one focuses only on the search
space of all the possible Boolean gene knockout configurations (as in Chapter 2), where
0/1 represents gene on/off, there are 21366 knockout configurations to be explored. If we
consider the gene expression as a continuous variable (as in Chapter 3), rather than a Boolean
variable, the problem becomes even more challenging. This state space explosion renders
the problem computationally intractable. The techniques developed in this dissertation, and
especially multi-objective optimization, are adopted to effectively search in this large space.
1.6.2 Algorithms for metabolic engineering
Interesting genes predicted through metabolic engineering algorithms are useful targets
to guide future experimental studies. The main challenge is that the overproduction of
a given chemical in the network usually comes at the expenses of a reduced growth rate.
Furthermore, microorganisms have evolved in order to rearrange the flux rates to guarantee
maximum production of biomass even after a genetic or environmental perturbation [79]. To
reflect this, in any metabolic engineering technique, maximum biomass formation must be
ensured after every genetic manipulation [183]. The most common computational methods
to perform metabolic engineering are OptKnock, OptFlux, OptGene, and GDLS.
OptKnock [30] uses bilevel linear programming to find and remove reactions whose
removal leads to a stronger coupling between biomass and synthetic objective. In large
systems, however, this does not necessarily ensure the production of the synthetic chemical
that the user needs to overproduce. Specifically, after eliminating the reactions suggested
by OptKnock, the model can sometimes avoid the formation of synthetic objective, for
particular shapes of the space of feasible objectives [130]. This is due to the presence
of a family of alternative solutions that could instead be captured using a multi-objective
approach. The main drawback of OptKnock is that it provides only one solution. To find
additional solutions, one has to run the algorithm again, by imposing the previous solution
as an additional constraint so that the same solution is not found again. This procedure is
similar to local search in optimization, and therefore does not allow an effective search in
the high-dimensional space of possible gene knockout strategies. Furthermore, it targets
reactions directly, and does not implement gene-protein-reaction associations that allow
searching knockouts strategies directly on genes.
OptFlux [136] and OptGene [127] implement respectively an evolutionary algorithm
and a simulated annealing meta-heuristic, both relying on a local search algorithm. GDLS
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[102] starts from an initial Boolean knockout strategy, and then seeks the best strategies that
differ from the starting strategy by at most K additional genetic manipulations, where each
manipulation consists of changing the state of a single gene (on or off). These strategies are
then evaluated using bilevel linear programming, and are used as a starting point for the
next round of K additional genetic manipulations. The procedure is then iterated until the
round of manipulations does not improve the solutions of the bilevel program. We remark
that a limitation of GDLS is not involving multi-objective optimization. In fact, the search
is only local and sequential, and each step depends only on the previous one. Furthermore,
in order to use GDLS, a model reduction is required.
GDMO, presented in Chapter 2, improves considerably on these aspects by allowing
evolution of the proposed Boolean gene knockout strategies. Furthermore, GDMO is a
multi-objective optimization evolutionary algorithm that controls a bilevel problem. More
specifically, the two objectives of the bilevel linear program become the two objective func-
tions of a multi-objective optimization algorithm, which does not weight them. As a result,
both objectives are maximized simultaneously and a Pareto front is produced. Conversely,
GDLS only uses bilevel optimization, and therefore intrinsically gives preference to the
first objective (biomass), which is the first level of the bilevel problem. Then, it compares
the proposed solutions by taking into account only the amount of second objective (acetate
or succinate exchange flux). As an optimization algorithm, GDLS can be though ot as a
single-objective version of GDMO, where the search is only local and the manipulations on
the proposed knockout strategies are only performed by an incremental mutation operator.
By directly comparing the solutions proposed by GDMO and GDLS on the same model
and with the same flux rates chosen as objectives, we will show that the solutions provided
by GDLS never outperform the Pareto fronts found by GDMO, since they occupy positions
in the area under the Pareto curves. In the best case, the GDLS solutions lie on the Pareto
front, which however contains additional solutions not found by GDLS.
A common drawback of these methods is that, although genome-scale models contain
reactions with information about the genes involved in their catalysis, they only capture
qualitative rules (e.g., a given reaction is turned off because it requires either gene A or gene
B, which are both off). These methods are therefore not sufficient to study the quantitative
effects of gene expression on the metabolism. METRADE, presented in Chapter 3, will
address this issue. Both GDMO and METRADE belong to the broad class of metabolic
engineering algorithms, as their goal is to maximize the growth rate and the production of a
chemical.
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1.7 Codon usage affects translation of genes into proteins
Natural selection acts as a driving force at virtually all levels of the genetic information
processing and biological organization: from DNA stability, replication and transcription
to messenger RNA, life span and efficiency of translation into proteins, to the correct
functioning of the metabolic network in the building up and propagation of a living organism.
Although, in principle, all these constraints could interact in a very complex way, it is indeed
fruitful to try to untangle the role of each element.
Codon usage bias is an important feature to take into account during the process of
translating genes into proteins. A codon is a triplet of DNA nucleotides that codes for a
specific amino acid. The process of translation of the genome allows expressing genes
into cellular functions. The translation of coding sequences into proteins starts when the
ribosome, a cellular structure where proteins are synthesized, is positioned on the AUG
codon (except for some genes using alternative start codons), followed by the polypeptide
synthesis in the ribosomal tunnel. The rate of protein synthesis depends on many factors,
e.g., the rate of transfer RNA (tRNA) binding and the kinetics of the process. Each tRNA
provides the code to assign a codon to a specific amino acid. A tRNA exposes an amino
acid and a nucleotide triplet (anticodon) that recognizes a specific codon. Specifically,
there are 20 amino acids and 43 codons, 61 of which actually encode for amino acids. An
amino acid can be encoded by one or more codons, while each codon encodes always for
the same amino acid [156]. In particular, an amino acid of a growing polypeptide chain
can be encoded by up to six codons. Codons coding for the same amino acid are referred
to as synonymous codons. The different tRNA species exposing the same amino acid are
differentially expressed: some tRNAs are more abundant than their synonymous cognates.
As a consequence, synonymous codons are not equivalent and are not used randomly.
The codon bias is strong in highly expressed genes, indicating that codon composition
has an impact on translation efficiency [121]. Specifically, high-frequency-usage codons
allow the quick generation of the polypeptide chain, while low-frequency-usage codons
slow down the translation process and allow the nascent protein to fold into a helical
structure [76, 171]. In this regard, it has been experimentally proved that replacing rare
codons with frequent synonymous codons improves the rate of translation [73]. The usage
of each codon reflects the amount of its corresponding tRNA. Differences in codon usage
frequency are therefore responsible for rapid or slow translation of genes into proteins, thus
affecting the gene expression process [33]. The codon usage in bacteria can modulate the
translation to reach the maximum rate of 15 amino acid per seconds on average. A good
estimate of the effect of codon usage on the translation process, with realistic assumptions
on the E. coli behavior, has been produced in [53].
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While FBA and flux optimization capture the behavior of an organism at steady state,
controlling and optimizing codon usage may also allow capturing the phenotypic noise
[141], therefore permitting the adaptation of the organism to a variety of environments. An
optimal codon usage also enables fast translation without misincorporations.
In Section 3.4, we will assess the genome-wide transcriptional and translational orga-
nization by analyzing the multi-objective optimization of the codon usage distribution in
genes, and how this affects the fluxes in the same pathway and the overall metabolism. By
modeling the codon bias in the FBA framework, in Chapter 3 we will establish estima-
tors (Pareto optimality and associated measures) of the transcriptional and translational
fitness bottlenecks in metabolic pathways. This represents a guide for practical solutions of
synthetic biology for gene design in natural strains.
1.8 Why adopting a multi-objective approach?
The question ‘what does a particular cell do?’ has often more than one correct answer.
A common assumption in systems biology is that microorganisms tend to optimize their
metabolic network in order to maximize the growth rate (biomass). However, whether the
biomass is the right objective for the analysis of the metabolism is still a matter of debate
[22]. There is increasing evidence that bacteria have to cope with multiple, sometimes
competing, objectives to optimize simultaneously [145], and a single objective function
is not able to capture these. It is also likely that metabolism is not fully optimized for
any particular objective [126], and evolution has shaped cells in order to reach an optimal
trade-off between all objectives [179].
This suggests that the commonly used single-objective approach, e.g., the maximization
of the growth rate, may not be appropriate in many systems biology applications. Therefore,
throughout this dissertation, we always take into account multiple objectives. An optimiza-
tion process that takes into account multiple objectives has also the advantage of ensuring
metabolic flexibility for possible reorganizations performed during adaptations to changes
in the environmental conditions. Finally, exploring a set of trade-off solutions between
competing objectives, rather than a single biomass-maximizing solution, also accounts for
suboptimal solutions [174].
Importantly, as detailed in Section 1.4, our multi-objective approach does not require the
combination of the objectives into a single objective function. In fact, no prior knowledge
is generally available on how two or more particular objectives are balanced in a given cell.
Therefore, rather than establishing weights for each objective and then combining them into
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a single objective, we optimize all the objectives simultaneously with a GA, providing the
final trade-off curve.
1.9 Structure of the dissertation
The remainder of the dissertation is organized as follows. In Chapter 2, we present a multi-
objective framework for analysis and optimization of genome-scale metabolic networks.
By using a multi-objective optimization method called Genetic Design by Multi-objective
Optimization (GDMO), which we published in [44], we maximize several pairs of biological
functions, such as acetate production and biomass formation.
In the optimization procedure, we search for the best genetic strategies that maximize
selected objectives. The results are represented as a Pareto front. The Pareto front is
a representation of the ability of the organism to respond to environmental changes by
exhibiting plasticity and ability to execute various cellular tasks. The area under the front,
the extension and the points of the front, the knees and the jumps are features that summarize
the characteristic phenotype of the organism, and are useful tools to cross-compare models
or different organisms. GDMO is then augmented with sensitivity and robustness analyses,
which provide a comprehensive assessment of the model under investigation and a post-
processing evaluation of the solution found by the optimization process.
To measure adaptability to changing environmental conditions and over time, in Chapter
3 we develop a multi-omic model of Escherichia coli that accounts for metabolism, gene
expression and codon usage at both transcription and translation levels. Bacterial phenotypic
traits and lifestyles in response to diverse environmental conditions depend on changes in the
internal molecular environment. However, predicting bacterial adaptability is still difficult
outside of laboratory-controlled conditions. Many molecular levels can contribute to the
adaptation to a changing environment, e.g., pathway structure, codon usage, metabolism.
After the integration of multiple omics into the model, we propose a multi-objective
optimization algorithm to find the allowable and optimal metabolic phenotypes through
concurrent maximization or minimization of multiple metabolic markers. In the condition
space, we propose Pareto hypervolume as a proxy for short-term multi-omic (transcriptomic
and metabolic) evolution, thus enabling comparative analysis of metabolic conditions. We
are therefore able to compare, evaluate and cluster different experimental conditions, models
and bacterial strains according to their metabolic response in a multidimensional objective
space, rather than in the original space of gene expression data (microarrays). Our approach
proves useful to integrate and assess multiple omic layers in a constraint-based model, and
is experimentally validated on a publicly available phenomics dataset of E. coli, and on a
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set of genome-scale reconstructions grown in a compendium of environmental conditions.
Our method, named METRADE, is freely available as a MATLAB toolbox.
In Chapter 4, we focus on the role that computation plays in the bio-inspired science.
This research field was pioneered by Turing in 1952 [162], who proposed computational
processes in morphogenesis. We propose a mapping between a living organism and the von
Neumann architecture, where the metabolism executes reactions mapped to instructions of
a Turing machine. A solution found by GDMO represents the optimal genetic knockout
strategy and can play the role of an executable program stored in the “memory” of the
organism. We adopt our framework to investigate scenarios of communication among
bacteria, gene duplication, and lateral gene transfer events. Finally, we use this mapping
to estimate the computational effort for a specific metabolic task, and the computational
capability of the organism as function of communication outcomes, e.g., gene duplication
events.
1.9.1 List of genome-scale metabolic models used
In each chapter, while the methodology is covered extensively, only the main results are
reported. The reader is referred to the related publications, listed at the end of each chapter,
for more details and for the full set of applications of the method. In Table 1.1, we list the
genome-scale models used in this dissertation.
Model Reactions Metabolites Genes Ref.
Escherichia coli iAF1260 2077 1039 1260 [60]
Escherichia coli iJO1366 2251 1136 1366 [119]
Human heart mitochondrion 253 245 n.a. [151]
Chlamydomonas reinhardtii (algal cell) 2190 1068 1080 [37]
Saccharomyces cerevisiae (yeast) 3493 2218 916 [14]
Corynebacterium glutamicum 518 399 468 [165]
Table 1.1 List of models, number of reactions, metabolites and genes used to test the
methodology proposed in this dissertation. We have excluded exchange reactions (i.e.,
those modeling the flow of metabolites, e.g., glucose and oxygen, in and out of the cell)
from the count. External exchange metabolites, representing one end of the exchange
reactions, are also excluded. The model of human heart mitochondrion does not contain
gene-to-protein association rules. In the last column we report the publication from which
the original model was initially extracted.
20
Chapter 2
GDMO: a comprehensive framework
for multi-objective Boolean optimization
of metabolic networks
In this chapter we propose a comprehensive optimization method, called Genetic De-
sign through Multi-objective Optimization (GDMO), that works at the genetic level of
a metabolic model and finds the genetic strategies to be followed in order to optimize
simultaneously multiple targets of interest. By exploring effectively the whole space of gene
knockouts, GDMO optimizes biomass, acetate and succinate production, as well as other
multiple biological functions, using FBA [120] and multi-objective optimization. We then
compare GDMO with state-of-the-art methods for genetic design, namely GDLS, OptFlux,
OptGene, OptKnock. Each point of the Pareto front proposed by GDMO represents a
different strain or the same strain adapting differently to various sets of environmental
conditions. Pareto optimality allows obtaining not only a wide range of Pareto optimal
solutions, but also the best trade-off design. GDMO has been developed in collaboration
with Dr J. Costanza, Dr G. Carapezza, and Prof G. Nicosia, all from the University of
Catania, Italy.
With the aim of investigating metabolic networks in an automated way, we included
GDMO in a framework consisting of a set of computational techniques: optimization,
sensitivity analysis, robustness analysis, ε-dominance analysis, identifiability analysis
(Fig. 2.1) [10]. The search for optimal configurations of the network is performed through
combinatorial operators in the space of gene knockouts, where each gene is modeled by a
Boolean on/off variable.
We seek the Pareto-optimal knockout strategies to simultaneously optimize two or
more objective functions. The sensitivity analysis quantifies the importance of the input
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Fig. 2.1 A framework for optimal design of metabolic networks. The optimization
framework is able to perform multi-objective optimization on genes and gene sets (sets
of genes coding for a protein each). The optimization is augmented with sensitivity,
identifiability, robustness and ε-dominance analysis.
variables in the model. The identifiability analysis infers functional relations between them.
The robustness is used in combination with the sensitivity and quantifies if a solution is
reachable even if small perturbations are applied to the system. The ε-dominance analysis
identifies sub-optimal points. Note that only sensitivity and robustness are presented in this
dissertation, while ε-dominance and identifiability analysis are covered in [10]. We apply
our methods to a set of genome-scale FBA models.
2.1 Genetic design through multi-objective optimization
(GDMO)
Genetic Design through Multi-objective Optimization (GDMO), which we published in [44],
is a genetic algorithm inspired by the Non-dominated Sort Genetic Algorithm 2 (NSGA-II)
[52], a combinatorial GA belonging to the class of evolutionary algorithms. GDMO is able
to optimize two or more objective functions, and to find a set of non-dominated (i.e., Pareto
optimal) solutions consisting of gene knockout strategies. The idea is that by finding the
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right combination of genes to turn off, one can improve the bacterial secretion of a desired
metabolite while keeping a high growth rate. Multi-objective optimization does not provide
a single optimal knockout solution (as it occurs in single-objective optimization problems),
but a set of finite optimal solutions that constitute the Pareto front.
GDMO, presented in Algorithm 1, seeks genetic knockout strategies able to simultane-
ously optimize multiple biological functions, e.g., maximization of biomass, maximization
of acetate and minimization of the knockout cost (number of genes to turn off). The idea is
that the multi-objective optimization algorithm proposes gene knockout strategies that are
subsequently mapped to the FBA model. FBA is then applied in a bilevel fashion, giving
preference to the biomass maximization over the maximization of the second objective.
The values of these two objectives (obtained starting from the gene knockout strategies)
are finally assigned to the objective functions of the optimization algorithm. Using the
non-domination principle described in Section 1.4, only the best strategies are kept, and
new strategies are generated using evolutionary operators. The process is iterated to create
the Pareto front. The advantage of using multi-objective optimization is that it does not
weight objective functions. However, in GDMO, the optimization algorithm is driving a
bilevel FBA model, which gives preference to one objective over the other. Therefore, the
order in which the objectives are considered in the bilevel FBA model might affect the final
Pareto front. As a result, prior to generalizing our approach, one should assess if the system
is sensitive to the order in which the two (or multiple) objectives are considered.
Searching for optimal genetic strategies has been modeled as a combinatorial problem,
since the genetic code can be represented by a binary vector y. Each element yl of y is a gene
set, i.e., a set of genes coding for enzymes, isozymes, or enzymatic complexes that catalyze
one or more reactions. Seeking genetic strategies means searching for the best binary
knockout vector, where the element yl is 1 if the lth gene set is turned off. In our method,
we consider a maximum number of knockouts, i.e., a maximum number C of elements in
y equal to 1. y is the vector of the decision variables to be optimized in the binary search
space. GDMO starts with the initialization of a population P. The population is formed
by individuals, where each individual is represented by a Boolean vector y representing a
knockout strategy. During the initialization, each individual can represent the wild-type
combination (all zeros), or can be obtained by random mutations.
When P is initialized, the fitness of all individuals is calculated. The fitness is defined
as the measure of rank and crowding distance. Rank values are assigned to each individual
based on whether or not they belong to the Pareto front. The crowding distance is a measure
of how much close an individual is to its neighbors. Large average crowding distance will
result in better diversity in the population, which is indeed one of the goals on GDMO.
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The next steps are repeated during the generations (or iterations) of the algorithm until
the number of generations or convergence is reached. In a selection step, 50% of best
individuals of P are chosen to generate the new offspring. Therefore, in a combinatorial
mutation operator (Algorithm 2) new individuals are created. This offspring population,
called p in Algorithm 1, is merged with the entire parent population P (this procedure,
called elitism, ensures that the best parents are kept in the following populations) and, using
a tournament selection, only the best I individuals are used to form the new population
P. In a tournament of two individuals (binary tournament), an individual is selected if its
rank is lower and its crowding distance is larger. The binary tournament selection ensures
that the best individuals in the population are selected based on their rank and crowding
distance. The new population P is used in the next iteration, and the process is repeated
until a stop condition is met or no further improvement is seen. At the last iteration, the
individuals contained in P constitute the optimal set of knockout strategies.
Our approach solves one of the most significant bottlenecks of FBA models, namely the
lack of control and optimization on genes. In this algorithm, an individual can be thought
of as a genetic variant or subtype of the organism (also called strain), characterized by
a specific gene expression profile. The populations of strains evolve towards an optimal
population, i.e., a population made up of the best strains for optimizing the objective
functions. This process mimics the feast and famine phases of the bacterial populations, in
which only the fittest phenotypes are kept.
The results obtained with GDMO are presented in Table 2.1, where its performance is
compared against alternative approaches for genetic design. To compare these methods,
we run OptKnock in its GAMS implementation [30], while the GDLS, OptGene and
OptFlux solutions are extracted by published data [102]. The E. coli network is initialized
with an empty set of knockouts (“wild-type configuration”). We let GDMO evolve 1500
populations of 1000 individuals each, where each individual represents a genome-wide
Boolean knockout strategy. We report the best solutions obtained by each method in terms
of biomass formation, acetate and succinate production. In designing knockout intervention
strategies, overproducing acetate and succinate is key for biotechnological or medical
purposes.
Acetate is an important target for biotechnology, with multiple industrial applications
[131]; it is central to many pathways in both aerobic and anaerobic E. coli metabolism.
Being an intermediate metabolite, it is representative of processes not directly related to
growth, and therefore it is highly indicative of metabolic flexibility for possible reorganiza-
tions that need to be performed during adaptations to environmental changes. When acetate
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Algorithm 1 GDMO pseudo-code
Require: [ f ,y, I,MAXgen,C,K]
/* f output of the FBA model (two flux rates, e.g., biomass and acetate)*/
/* y knockout vector of length L */
/* L number of gene sets */
/* I number of individuals surviving in each population */
/* MAXgen maximum number of populations */
/* C maximum number of knockouts allowed*/
/* K number of new children generated by each best individual */
1: P1 ← initial population with random binary vectors y˜ or null wild-type vectors y
2: Evaluate the rank (fitness) f of all individuals
3: for i← 1 to MAXgen do
/* Define pi selecting the best I/2 individuals of population Pi according to the NSGA-II [52]
tournament selection (lower rank and higher crowding distance). The set of individuals pi
will then be used to generate a mutated set p˜i, which will be finally merged with the current
population Pi. The new merged population Qi will undergo a tournament to select the individuals
that will constitute the new population Pi+1 for the next iteration of the algorithm */
4: pi ← Tournament Selection(Pi)
5: pi ← best I/2 individuals from pi
6: for h← 1 to I/2 do
/* for each individual pi,h of population pi we perform the Mutation operator (Algorithm
2) sequentially and obtain K mutated children, but only the best child will be selected to become
an individual of the mutated set p˜i*/
7: y˜i,h,1 ← Mutation(pi,h,C/L)
8: for j ← 2 to K do
/* perform Mutation for the most recent child y˜i,h, j−1 and create a new child y˜i,h, j*/
9: y˜i,h, j ← Mutation(y˜i,h, j−1,C/L)
10: end for
11: Evaluate the rank (fitness) of the K children y˜i,h, j, j = 1, . . . ,K
12: Select the best child y˜i,h, j∗ from y˜i,h,1, . . . , y˜i,h,K
13: p˜i,h ← y˜i,h, j∗ /* p˜i,h is the best mutation of pi,h, h = 1, . . . , I/2 */
14: end for
15: Qi ← Merge Pi with p˜i /* Qi contains I+ I/2 = 3I/2 individuals now */
/* Perform Tournament Selection on Qi and obtain the new Pi+1 */
16: Pi+1 ← Tournament Selection(Qi)
17: Pi+1 ← best I individuals from Pi+1 /* The final population always contains I individuals
*/
18:
19: if (stop condition met) OR (no improvement in Pi+1 compared to Pi) then
20: return Pi+1
21: end if
22: end for
23: return Pi+1
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Algorithm 2 Mutation pseudo-code
Require: [x,α]
/* α ∈ [0,1] is a real constant and defines the maximum amount of mutations that can be
undergone by the Boolean vector x of L elements*/
/* Select randomly an integer value b in [0,⌊αL⌋] */
1: b← random (αL)
/* Select randomly b bits in x */
2: ind ← random (L,b)
/* Flip bits selected */
3: x[ind]← not(x [ind])
4: return x
is present at high levels, it inhibits cell growth and recombinant protein productivity [54].
In our simulations, we require at least 0.05 h−1 of biomass.
As shown in Table 2.1, with respect to the wild-type bacterium, GDMO and the other
methods propose strategies that guarantee a high production of acetate or succinate, at the
expense of the growth rate. GDMO finds the knockout strategies that yield the largest value
of acetate (19.150 mmol h−1 gDW−1) and succinate (10.610 mmol h−1 gDW−1). Both
solutions by GDLS are outperformed by the second and third solution (respectively) by
GDMO. The first OptKnock solution is outperformed by the first GDMO solution. The
second OptKnock solution is outperformed by the third GDMO solution only in terms
of succinate, but not in terms of biomass. However the solution proposed by OptKnock
is penalized by a large knockout cost (defined as the number genes to be turned off to
implement the strategy). GDMO overcomes the other methods also proposing strategies
with a lower knockout cost. We remark that a low knockout cost is a desirable feature
when implementing these strategies in vitro. Many solutions proposed by the methods
evaluated in this comparison have a knockout cost that would render the solution very
hard to reproduce in laboratory (for instance, OptKnock finds solutions that would involve
turning off 53 or 54 genes).
When we consider the problem of maximizing acetate/succinate production and biomass
formation by searching for genetic manipulations in an FBA context, we take the on/off
status of reactions as our decision variables, and we solve a conflict problem of maximization
because the increase of one objective function (e.g., acetate) implies the decrease of the other
(biomass). In this case, the slope of the Pareto front reflects a progressive lack of pathways
to sustain the production of one component when we are optimizing the metabolism to
maximize the other. “Jumps” (quick decreases or missing parts) mark the sudden loss
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of pathways due to the critical unavailability of an enzymatic step. In other words, they
correspond to sudden decreases in the availability of entire pathways and subnetworks when
a crucial hub is eliminated (e.g., the Krebs cycle). The region of the Pareto front near a
jump suggests that slight changes of conditions, or a handful of genetic mutations, may
result in a large change in the amount of product.
2.2 Robustness analysis
The ability of a system to adapt to perturbations due to internal or external agents, aging,
temperature, environmental changes and, in our case, also due to molecular noise and
mutation is one of the fundamental design principles. To optimize the production of a
specific metabolite (and simultaneously the formation of biomass, which is necessary to
maintain the survival of the bacterium), we first use GDMO in order to obtain a strain that
maximizes the features required by us. At this point, the validity of the biological strain,
designed in-silico, must be tested as regards the robustness and sensitivity to endogenous
and exogenous perturbations. A robustness analysis is able to assess the ability of a strain
to adapt to small perturbations that can occur at any stage of the biochemical processes
within the bacterium, or are caused by the environment in which it reproduces. By the
term “robustness” we mean the ability to maintain an acceptable performance relative to
the metabolite production and biomass formation that were previously optimized from a
multi-objective standpoint, even after small perturbations that the system might undergo.
There are numerous methods that can be used to fulfil this task. For instance, the theory
of percolation on random graphs can be used to test the robustness of the network in case
of random or targeted node deletion, or in case of random link deletion [32]. Additionally,
the relationship between the general characteristics of a chemical reaction network and the
sensitivity of its equilibrium can be investigated by perturbing the overall supply of reagents
[148]. Finally, in [74], a combined approach of global and local robustness is proposed,
named glocal robustness. The global analysis investigates the parameter space with the aim
of finding where a circuit cell shows experimentally-observed features, while the local one
determines the robustness of parameter sets sampled during the previous phase.
Here we adopt a simple definition of robustness analysis, easily applicable to similar
problems in other fields. The basic principle of this analysis is as follows. First, we define
the perturbation as a function τ = γ (Ψ,σ) where γ applies a stochastic noise σ to the
system Ψ and generates a trial sample τ . The γ-function is called γ-perturbation. Without
loss of generality, we assume that the noise σ is defined by a random distribution. In order
to perform a statistically-meaningful calculation of robustness, we generate a set T of trial
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samples τ . Each element τ of the set T is considered robust to the perturbation, due to
stochastic noise σ , for a given property (or metric) φ , if the following test gives 1 as result:
ρ (Ψ,τ,φ ,ε) =
1, if |φ (Ψ)−φ (τ) | ≤ ε0, otherwise (2.1)
where Ψ is the reference system, φ is a metric (or property), τ is a trial sample of the set
T and ε is a robustness threshold. The definition of this condition makes no assumptions
about the function φ , which is not necessarily related to the properties of the system, but
must be quantifiable. The robustness Γ of a system Ψ is the number of robust trials of T,
with respect to the property φ , over the total number of trials (|T |). Formally:
Γ(Ψ,T,φ ,ε) = ∑τ∈T
ρ (Ψ,τ,φ ,ε)
|T | , (2.2)
where Γ is a dimensionless quantity that states, in general, the robustness of a system and,
in our case, of an E. coli strain taken from the Pareto front.
The robustness index is a function of ε and σ , so the choice of these parameters is crucial
and not a trivial task. Since we are interested in the behavior of a strain when subjected to
small perturbations, and given that the behavior is acceptable when the deviations from the
original value is as small as possible, we generate trial samples τ by choosing ε in the range
0%−10% of the metric φ (Ψ) and σ in the range 0%−10% of the perturbed variable in
Ψ. Based on this principle, we evaluate two values of robustness: the Global Robustness
value (GR), and the Local Robustness value (LR). These two values only differ in the type
of perturbation applied and, specifically, once σ is fixed they differ in the set of variables
perturbed.
Global Robustness. As regards the global robustness of a strain, a trial τ is created by
perturbing all the upper bound vUj and lower bounds v
L
j , j = 1, . . . ,n of the metabolic fluxes.
We create a set T of trials, and for each of them we simultaneously perturb all the bounds
and evaluate the property φ(τ) (through FBA), which in our case can be the value of acetate,
succinate, biomass or a combination of them; then, we calculate the function ρ . Once a
value of ρ is obtained for each trial, we compute the value of robustness (Equation 2.2),
which in this case we call Global Robustness because all the parameters are perturbed.
Local Robustness. In this case, we perturb again the upper bound vUj and lower bound
vLj , j = 1, . . . ,n, of a metabolic flux. We create a sample trial by perturbing a single flux, we
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Fig. 2.2 Local (A) and global (B) robustness variation versus σ and ε values in E. coli
iAF1260. σ is proportional to the perturbed parameters (lower and upper bounds of the
fluxes), while ε is proportional to the metric (in this case acetate and biomass productions).
For the local value, we report the minimum value found (this value is associated with the
glucose uptake rate).
evaluate the property φ(τ), and we calculate the function ρ . After creating a set Tτ of trials,
we calculate the robustness (Equation 2.2), which in this case we call Local Robustness.
Hence, the LR value is computed for each metabolic flux, and the value of interest is the
minimum LR index found, which is large for robust systems. In Fig. 2.2 we show the
robustness values found in the E. coli model iAF1260 as a function of ε and σ .
The robustness results associated with the solutions computed by GDMO are presented
in Table 2.1. The robustness of the solutions generated by GDMO is larger than the robust-
ness of the solutions generated through GDLS. OptKnock also ensures high robustness.
Unsurprisingly, the most robust strain is the wild-type E. coli, as it did not undergo any
genetic manipulation. Indeed, we expect that a wild-type bacterium is in a stable and robust
metabolic state, while an engineered organism is able to overproduce a given metabolite at
the expense of robustness.
2.3 Sensitivity analysis
Sensitivity Analysis (SA) is a method for identifying the importance of the components
(inputs) in a model. Recently, SA has been applied to evaluate reactions (RoSA - Reactions
oriented Sensitivity Analysis) [157] and species (SoSA - Species oriented Sensitivity
Analysis) [181]. Here, the idea is to perform a pathway-oriented SA (PoSA), with the aim
of detecting the most sensitive pathways in the FBA model of E. coli. Unlike standard SA
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methods, whose inputs (reactions or species) are real-valued, PoSA is applied with Boolean
inputs representing the presence or absence of each reaction in the metabolic network.
2.3.1 Morris’ sensitivity analysis
The standard approach to sensitivity analysis was pioneered by Morris [115]. Specifically,
the input factor space of a model is discretized and the possible input factor values are
assumed to be inside a regular k-dimensional t-level grid, where t is the number of levels of
the design. The elementary effect of a given value xi on a given output G is defined as a
finite difference derivative approximation, called elementary effect:
EEi(x) =
G(x1,x2, ...,xi−1,xi+∆,xi+1, ...,xk)−G(x)
∆
, (2.3)
for any xi between 0 and 1−∆, where x ∈ {0,1/(t − 1),2/(t − 1), . . . ,1}k, and ∆ is a
predetermined multiple of 1/(t−1) that ensures that small perturbations with a big impact
on G are assigned a large EE. The influence of xi is then evaluated by averaging several
elementary effects at randomly selected values of xi on the grid. The idea is to assess the
importance of each input xi with a number of elementary effects proportional to k. If all the
samples of the elementary effect of the ith input factor are zero, then xi does not have any
effect on the output, and the sample mean and its standard deviation will both be zero. For
more complex interactions, due to interactions between factors and nonlinearity, high mean
indicates a factor with an important overall influence on the output; high standard deviation
indicates that either the factor is interacting with other factors or the factor has nonlinear
effects on the output.
In Fig. 2.3, we show the result of the Morris method considering as input the uptake flux
rates in the genome-scale metabolic network of the mitochondrion [151], and as output the
array v of flux distribution. As a consequence we remark that, in this case, the numerator in
(2.3) is replaced by the Euclidean distance ∥v(x1,x2, ...,xi−1,xi+∆,xi+1, ...,xk)− v(x)∥. In
the plot, we report the mean and the standard deviation of the distribution of elementary
effects for each input. We note that the effect of varying the oxygen exchange flux is
considerably higher than the effect of varying any other import flux. This is also confirmed
by the different metabolic configurations that a bacterium adopts in aerobic versus anaerobic
regimes. While the mean of the elementary effects is proportional to their variance for
many exchange fluxes, maintaining both µ and σ is crucial in different types of sensitivity
analysis, e.g., PoSA presented in the next section.
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Fig. 2.3 Sensitivity analysis on the mitochondrial FBA model. We consider as input the
uptake flux rates in the genome-scale metabolic network of the mitochondrion [151], and as
output the array of flux distribution. The plot shows the mean µ and the standard deviation
σ of the elementary effects computed through the Morris method (2.3) applied on the upper
bounds of the exchange reaction fluxes. The legend ranks the inputs from the most to the
least important in terms of sensitivity.
2.3.2 Pathway-oriented sensitivity analysis
PoSA (Pathway-oriented sensitivity analysis) investigates the knockout solution space and
determines the influence of the pathways on the outputs of an FBA model. Since GDMO
provides a set of feasible solutions with different genetic manipulations, investigating
the PoSA sensitivity indices starting from the solutions will establish a relation between
pathways and proposed manipulations, therefore allowing us to select only certain knockout
strategies on the Pareto front. For instance, after the GDMO optimization, a possible use
of PoSA is to help in selecting only those GDMO knockout strategies that affect genes
belonging to insensitive pathways.
In PoSA, the knockout vector y used to represent the genetic manipulations is partitioned
in p subsets of binary variables
{
b1,b2, . . . ,bs, . . . ,bp
}
, where each bs includes the genetic
manipulations linked to the reactions involved in the sth metabolic pathway of the network,
and |bs|=Ws (number of genes in the sth pathway). The genes in the network are clustered
in metabolic pathways based on the metabolic model and on previous knowledge on
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metabolic networks [60]. Each pathway performs a particular task in the metabolism, e.g.,
the citric acid cycle, the oxidative phosphorylation, or the pentose phosphate pathway.
As part of the sensitivity evaluation, PoSA generates: (i) gene-pathway mappings (GP),
defined as a L× p matrix P, where the (l,s)th element of P is 1 if the lth gene controls a
reaction of the sth pathway, and 0 otherwise; (ii) reaction-pathway mappings (RP), defined
as a n×p matrix R, where the (j,s)th element of R is 1 if the jth reaction belongs to the sth
pathway, and 0 otherwise.
PoSA is able to rank the pathways of the metabolic network by perturbing genes in
terms of knockouts. All genes in a pathway bs are perturbed randomly. The output(s) of the
model is compared with the output without the pathway perturbation. We consider as output
the vector of the fluxes after performing flux balance analysis and perturbing pathways.
PoSA performs combinatorial perturbations, since gene knockouts are represented by binary
variables.
We define the “pathway elementary effect” for the pathway bs as
PEEs =
∥v(b1,b2, . . . ,bs−1, b˜s,bs+1, . . . ,bp)− v(y)∥
∆s
, (2.4)
where ∥ · ∥ is the 2-norm (Euclidean distance), v returns the vector of flux rates, b˜s
indicates a mutation on the pathway bs, and consists of flipping bits indicating activation
status of genes chosen randomly in bs: if a bit is 0 (or 1), the permutation turns it to 1 (or
0). y is the starting genetic strategy in which we are interested in computing the pathway
sensitivity. ∆s is a scale factor defined as ∆s = 1Ws
Ws
∑
i=1
b˜s(i), s = 1, . . . , p.
Note that if a gene bs(i) in bs is set to 1, it is knocked-out in the model; therefore, ∆s
is low if there is a low number of knocked-out genes, and as a result PEE is inversely
proportional to the number of knocked-out genes. This correctly detects large changes
caused by pathways in which only a few genes have been turned off. In the following
applications, y is the strategy where all genes are activated and fully working in the
metabolism. However, for instance, y can be a strategy on the Pareto front after multi-
objective optimization. Indeed, evaluating the pathway-based sensitivity of each solution
on the Pareto front is a useful criterion to select the least sensitive Pareto-optimal strategy,
which is therefore safer to implement in vitro.
For each pathway bs, 40 iterations are performed; at each iteration, an elementary effect
is computed using (2.4), where b˜s indicates that a number of bits (indicating gene activation
status) are flipped in the sth pathway only. For each iteration, both the actual bits flipped in
the knockout strategy (with respect to the initial strategy y) and the number of bits flipped
is chosen randomly. The number of bits flipped is between 1 and 10% of the genes in the
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pathway. After all the iterations are completed for the sth pathway, the average elementary
effect µ and its standard deviation σ are computed across the iterations.
In Fig. 2.4 we show the pathway sensitivity analysis applied to a model of the algal
metabolism of C. reinhardtii [37]. The distribution of elementary effects is obtained by
randomly choosing the bits to flip (i.e., genes to turn off or on). If y represents the initial
all-active strategy, the mean µ and the standard deviation σ are used as an indicator of which
pathway should be considered important in the overall metabolism. Similarly to Morris’
sensitivity analysis, high mean indicates a pathway with an important overall influence on
the output, while high standard deviation indicates a pathway whose effect is nonlinear or
highly dependent on the effect of other pathways. In general, in the (µ,σ ) space, highly
networked cell components (e.g., those of nucleic acids, amino acid, cofactors and energetic
metabolism) are at the top right. Specific, often single-reaction and abundant components
(e.g., those for bacterial walls, nitrogen, glutamic and carbohydrates) are at the bottom left.
As shown in Fig. 2.4, knockouts in the set of reactions representing transport of
molecules in and out of the two organelles (mitochondrion and chloroplast) are detected
to be the most important in shaping the flux distribution. Surprisingly, the key pathways
of pyruvate metabolism and TCA cycle are less important than the two sets of transport
reactions, while still being two of the most important pathways in the overall metabolism.
Compared to these key pathways, the transport reactions show a smaller value of σ , there-
fore indicating that their role in shaping the value of the objective function is less dependent
on the other pathways. Surprisingly, although glycolysis/gluconeogenesis is the central core
of bacterial biomass and energy storage, it is not ranked high by PoSA. More generally,
pathways can also be clustered according to their position in the PoSA plot, which indicates
their actual metabolic relevancy towards the selected objective function v.
2.4 A new FBA model: the hydrogenosome
In several unicellular eukaryotes, including ciliates, fungi, and trichomonads, instead of the
traditionally studied mitochondria, there is an alternate organelle called hydrogenosome.
Hydrogenosomes are anaerobically functioning ATP-producing organelles of mitochondrial
origin that represent a particular adaptation of mitochondrial metabolism, and possess the
ability of producing molecular hydrogen by using protons as electron acceptor [164]. One
of the best studied hydrogenosomes, and thus the one that we consider in our analysis, is
that of the sexually transmitted human parasite Trichomonas vaginalis [106].
Hydrogenosomes are double-membrane bound organelles. Although they were first
thought to be distinct and of independent origin, the finding of a chromosome-bearing
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Fig. 2.4 PoSA applied to the algal metabolism of C. reinhardtii. Each perturbation is
performed through on/off flipping of a number of genes, and the full vector of flux rates
is evaluated as output v. For each pathway, the mean µ and the standard deviation σ are
computed from the distribution of pathway elementary effects (2.4). In the legend, only the
most sensitive pathways are reported.
hydrogenosome from the ciliate Nyctoterus ovalis, and the analysis of its sequence, proved
their evolutionary relatedness with mitochondria [25]. Nowadays, it is widely accepted that
hydrogenosomes are mitochondrial adaptations to anaerobic lifestyles appeared throughout
the evolution of eukaryotes [164], although the mitochondrial ancestor (free-living bacteria
that lived in the cell as endosymbionts) and the evolutionary driving force behind endosym-
biosis are topics still open to debate. In addition to lacking mitochondria, all the organisms
containing hydrogenosomes are facultative anaerobes.
The proteome of the hydrogenosome in T. vaginalis consists of around 200 different
proteins; it is therefore significantly smaller than the proteome of yeast mitochondria. The
hydrogenosome produces molecular hydrogen, acetate, carbon dioxide and ATP by the
combined actions of pyruvate:ferredoxin oxido-reductase, hydrogenase, acetate:succinate
CoA transferase and succinate thiokinase. In particular, pyruvate is broken down to acetate,
CO2, and molecular hydrogen. This process is coupled with ATP formation through
phosphorylation. Since this organelle is not invasive, it remains outside the cell, thus it
needs ATP to move and adapt to varying external conditions, e.g., to resist the immune
system of the hosting organism.
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The unifying features of mitochondria, mitosomes, mitochondrion-like organelles
(MLOs), and hydrogenosomes are quite sparse. Almost all these organelles are linked
by the metabolic process called Fe-S cluster assembly. The presence of cpn60 is also a
unifying feature. Research on these mitochondrion-related organelles showed that ATP is
not produced in all described mitosomes. Therefore, contrary to what was postulated at
the beginning, energy production appears to be not the only driving force behind selection
for organelle retention. Nevertheless, these organelles continue to keep at least part of the
pathway involved in Fe-S cluster production [146]. It is noteworthy that ATP production
in hydrogenosomes occurs through catalysis by succinyl CoA synthetase, a Krebs cycle
enzyme that catalyzes the same reaction in hydrogenosomes and mitochondria.
Biochemical analyses of hydrogenosomes have also revealed significant differences be-
tween mitochondria and hydrogenosomes [29]. For instance, the enzyme responsible for the
decarboxylation of pyruvate in hydrogenosomes, i.e. pyruvate/ferredoxin oxidoreductase,
is significantly different from its counterpart in mitochondria, i.e. the pyruvate dehydro-
genase complex. Likewise, the hydrogenase is possessed only by the hydrogenosome,
and mitochondria cannot produce molecular hydrogen. Remarkably, pyruvate/ferredoxin
oxidoreductase and hydrogenase are commonly found in anaerobic bacteria.
Recent research shows that the RuBisCO protein may be found in the hydrogenosome
[144]. This finding can play a key role in understanding other hidden roles of RuBisCO
in nature. Indeed, the hydrogenosome is the result of a genome reduction undergone by
a common ancestor, and given that the RuBisCO is a vegetal protein (the most important
protein in chloroplasts), apparently it is not needed in the hydrogenosome. Consequently,
the presence of RuBisCO might suggest that it has a different role.
In order to investigate the hydrogenosome with the same techniques introduced before,
we propose a model of the hydrogenosome metabolism in T. vaginalis and we evaluate
the ATP flux. The model we propose is an FBA model that contains all the main reactions
occurring in the organelle [117, 144] (see Table 2.2), as well as reactions dealing with
the import of serine, glycine, pyruvate and malate into the hydrogenosome. Although our
model already shows interesting behaviors, we plan to extend it by adding new reactions.
To our knowledge, no hydrogenosome models are present in literature, thus we believe our
model will have great value as the best description that we have to date of this organelle,
and will provide a foundation upon which more accurate models can be built. A complete
model of the hydrogenosomal metabolism would be of great biological relevance in the
design of new antiparasitic drugs [106].
We specify the reaction network of the hydrogenosome through the LIM package of R,
which allows generating the mass balance for each component. The list of reactions used
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in the FBA framework is given in Table 2.2. Moreover, we estimate the optimal reaction
rates in the FBA approach. In Fig. 2.5 we show the results of FBA carried out on the
hydrogenosome model. The maximization of the ATP yield implies the consumption of
all the H2, CO2 and NADH in the organelle. The maximization of CO2 implies also the
maximization of H2, but requires the maximum import of malate, pyruvate and glycine.
Moreover, it impairs the NaFe reaction, thus keeping the NADH at the initial value. The
two-objective optimization of ATP and NADH causes the impairment of the Hydro reaction,
thus the hydrogenosome cannot produce H2. It is therefore evident that the hydrogenosome
needs a Pareto-optimal trade-off between energy and H2 production.
In order to obtain the optimal solution in all feasible two-objective optimizations, we
randomly sample the solution space. In Fig. 2.6 we display the pairs plot and mark the
optimal solution with a red dot. Most reactions are coupled together; it happens frequently
that a reaction can occur only when the substrates, which are products of another reaction,
are available. For instance, the ATP production depends on the acetate production, since
ATP requires SuccinylCoA, which is a product of the same reaction that produces acetate.
It is noteworthy that a few reactions are in conflict with all the other reactions. For instance,
the NaFe reaction, which produces NADH, is in conflict with Hydro, which produces
H2. Indeed, the last row of the pairs plot shows that the NADH production is in conflict
with H2 production. The presence of a feasible point in this plot does not imply that the
hydrogenosome metabolism, even if optimized, is able to reach that point. Notably, the
CO2-NADH plot shows that the hydrogenosome is versatile and can produce both, but it
cannot specialize in producing only one metabolite, since there are less points near the axes
and the Pareto front exhibits a higher curvature than the other fronts.
As shown in the previous sections, the FBA approach proves very useful when one
needs to investigate the effect of gene/reaction knockouts. In order to impair a reaction, its
lower and upper bounds can be set to zero. In Fig. 2.7 we show the output fluxes obtained
re-running the metabolic network when the mevalonate kinase (MevKin) is impaired. Since
the ATP is involved in this reaction, the maximization of ATP and NADH does not yield
the same result of Fig. 2.5c for the output flux of ATP. Another possible use of our model is
an insight into the optimization of more than two objectives (Fig. 2.8), which often requires
finding trade-offs.
2.5 Related work and final remarks
Additional techniques (ε-dominance and identifiability analysis) to drive and complement
the optimization process were excluded from this dissertation. The ε-dominance Pareto
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Fig. 2.6 Two-objective optimization carried out on metabolites and reaction fluxes.
The points represent a Markov chain Monte Carlo (MCMC) sampling of the reaction
network carried out with 20000 iterations, and allow finding trade-offs among the maxi-
mizations carried out in Fig. 2.5. When two reactions are mostly uncorrelated with one
another, all the solutions are feasible, thus the sampling tends to a filled square (e.g., the
output of H2 and CO2 shown in the upper-left corner). Conversely, when two reactions
show correlation, the MCMC sampling of the square reveals their relationship. For instance,
the NADH output and the H2 output are in contrast with each other. The red dot is the
optimal point.
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Fig. 2.7 MevKin knockout analysis. When the mevalonate kinase (MevKin) reaction is
impaired, a knockout is performed on the metabolic network. As a result, the maximum
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Fig. 2.8 Trade-offs in the five-objective optimization of the hydrogenosome. The si-
multaneous maximization of ATP, NADH, acetate, CO2 and H2 production is not possible
without finding a trade-off. In this case, compared to Fig. 2.5b, the CO2 cannot reach
its maximum value due to the constraints of the metabolic network and to the concurrent
maximization of the other four objectives.
front analysis extends the search space of solutions revealing other suitable (suboptimal)
points. The Identifiability Analysis (IA) seeks the functional relations underlying the
components of a given system, and can be used after the multi-objective optimization.
Coupled with the sensitivity analysis, it gives insight into the model under investigation.
A component of a model is said to be non-identifiable if there is no unique solution
for its estimation. The non-identifiability can be (i) structural, when there are functional
relations among components and therefore they cannot be determined unambiguously, or
(ii) practical, when the low amount or quality of data available does not allow one to have
a good estimate for the component. From the definitions, it follows that if a model is
structurally non-identifiable, it is also practically non-identifiable. Using repeated fitting to
data and estimations of components, the IA is aimed at finding the structural non-identifiable
components of a model, providing hints for simplifying the model and thus avoiding
redundancy, or indicating where new experimental measures are needed to guarantee the
identifiability of the model. In a related work, we use IA to characterize monogenic
mitochondrial diseases. Our idea is that by performing IA in simulated healthy, pathological
and disease conditions in a mitochondrial FBA model [151], we can characterize the onset
of a disease by looking at the functional relations among flux rates. For instance, in a
monogenic disease called α-ketoglutarate dehydrogenase deficiency, we simulate three
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stages of the disease (healthy, inflammation and pathological stages) depending on the
production of ATP. Interestingly, we find for the three stages that most functional relations
between fluxes in the pathological stage have a different shape with respect to those found
in the healthy and the inflammation stages (Fig. 2.9).
Part of this chapter has been published in Bioinformatics [44]. The optimization
and the associated analyses were performed in collaboration with my co-authors. The
hydrogenosome model, contributed by me, has been published in IEEE Transactions on
Computational Biology and Bioinformatics [7]. The full pipeline, including ε-dominance
and IA, has been published in PLoS One [10].
42
2.5 Related work and final remarks
-2 0 2 4 6 8 10 12 14 16
x 10-28
-2
-1
0
1
2
R00713MM: Succinatesemialdehyde+NAD++H2O-->Succinate+NADH+H+
β
-2 0 2 4 6 8 10 12 14 16
x 10-28
-2
-1
0
1
2
R01648MM: 4-Aminobutanoate+2-Oxoglutarate --> 
-->Succinatesemialdehyde+L-Glutamate          
β
-1 -0.5 0 0.5 1 1.5
x 10-27
-2
-1
0
1
2
R00713MM: Succinatesemialdehyde+NAD++H2O-->Succinate+NADH+H+
β
-1 -0.5 0 0.5 1 1.5
x 10-27
-2
-1
0
1
2
R01648MM: 4-Aminobutanoate+2-Oxoglutarate -->
-->Succinatesemialdehyde+L-Glutamate         
β
-1.5 -1 -0.5 0 0.5 1 1.5 2
x 10-28
-2
-1
0
1
2
R00713MM: Succinatesemialdehyde+NAD++H2O-->Succinate+NADH+H+
β
-1.5 -1 -0.5 0 0.5 1 1.5 2
x 10-28
-2
-1
0
1
2
R01648MM: 4-Aminobutanoate+2-Oxoglutarate -->
-->Succinatesemialdehyde+L-Glutamate         
β
Fig. 2.9 α-ketoglutarate dehydrogenase deficiency - healthy stage (top), inflammation
stage (middle), pathological stage (bottom). Similar behavior of β (y axis) indicates
strong functional relation between reactions [10], whose flux rate is on the x axis. These
relations have been found for the pair of reactions R00713MM and R01648MM (x axis)
[µmol min−1 gDW−1] in the mitochondrial FBA model [151]. The figure shows how
different stages of the disease imply different shapes of β , and therefore different functional
relation between the two reaction fluxes.
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Chapter 3
METRADE: continuous optimization
and environmental adaptability in
multi-omic networks
In Chapter 2 we did not consider the environmental condition in which the bacterium
is operating, and we also assumed that all genes are equally expressed. However, all
organisms experience oscillating conditions that range from starvation to food richness. In
particular, environmental changes represent the availability of different sources of food and
constitute different growth conditions. Therefore, the optimization of multiple objectives
should also indicate the capability of the organism to cope with these changes. To this
end, in this chapter we propose a method to enable multi-omic flux balance analysis and a
characterization of the space of environmental conditions.
We derive a multi-omic model for the Escherichia coli able to account for the adapt-
ability to multiple environmental conditions, and for the temporal evolution towards the
production of selected metabolites. The multi-omic model is part of a pipeline called
METRADE (MEtabolic and TRanscriptomics ADaptation Estimator), where the response
to the environmental conditions is then mapped to a multidimensional objective space
and analyzed with various estimators. METRADE also finds the optimal gene expression
profiles towards the multi-objective optimization of the production of chemicals of interest.
Unlike GDMO, METRADE treats gene expression as real-valued variables representing
expression levels, and not as Boolean gene knockouts.
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3.1 Estimating bacterial adaptability in changing environ-
mental conditions
Many molecular levels can contribute to adaptability: pathway structure, codon usage,
metabolism. For instance, the structure of the metabolism and the pathway productivity can
evolve in time due to varying environmental conditions or selective pressure [123]. Analo-
gously, several recent examples show the coupling of codon usage to adaptive phenotypic
variation, suggesting that the genotype functionality and behavior can be derived from the
analysis of the evolution in the codon usage [94]. Typically, the correlation between gene
expression and codon bias is large for environments similar to those in which the organism
evolved, and small for dissimilar environments [169].
In this chapter, we explore bacterial adaptability by investigating experimental condi-
tions mapped to a multidimensional objective space. To obtain a phase-space of conditions,
we add the continuous gene expression and the codon usage layers to an FBA framework,
therefore proposing a new multi-omic FBA model. As a first result, we are able to optimize
these layers for the overproduction of metabolites of interest, predicting the short term
bacterial evolution towards the optimum. Then, we present a new method to map gene
expression profiles to any metabolic objective space. Since each profile is associated with
a growth condition, the objective space becomes the condition phase-space, which we
investigate through principal component analysis.
To build the multi-omic model, we map gene expression and codon usage to the
metabolism by proposing a bilevel formulation that defines the flux bounds as a continuous
function of the related expression data. We therefore provide a different model for each
gene expression profile (environmental condition). This step is highly customizable in that
it is possible to select a different map for each reaction in the model, thus allowing for
the introduction of additional omic data, e.g., protein localization or stochasticity in the
protein abundance. The type of reaction-specific information that can generate a custom
map for given reactions is, for instance, the four-fold activity reduction in the isocitrate
dehydrogenase enzyme when taking acetate as the carbon source [128]. In other words, we
are able to generate a model tailored to any specific environmental or internal condition.
The model can be further optimized by finding the optimal codon usage for a given array of
gene expression.
To optimize the multi-omic layers, we propose a genetic multi-objective optimization
algorithm that seeks the gene expression profiles that optimize multiple cellular functions
concurrently. We use the Pareto front as a tool to seek trade-offs between two or more
tasks performed by E. coli, and specifically to score the performance when the tasks are
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contending with one another. We simultaneously optimize two or more tasks by finding
the best gene expression profile and codon usage array. Most notably, this may permit to
determine the best environmental condition in which a bacterium has to be grown in order
to reach specific optimal output values measured in the range of objective functions chosen
by the researcher. As a particular case, it is also possible to investigate the best single or
multiple gene knockouts for the given set of objectives [158].
The rest of the chapter is organized as follows. First, we define the new multi-omic
model by adding gene expression and codon usage layers to FBA, in order to build the level
of information required for a meaningful understanding of the landscape of experimental
conditions. Using this augmented FBA framework, we optimize the model and we perform
a temporal analysis of bacterial evolution towards an optimal configuration using the
hypervolume indicator. Then, we introduce principal component analysis to identify
conditions mapped to close regions in the phase-space. The main steps of our pipeline,
named METRADE, are illustrated in Fig. 3.1, with pointers to the sections where each step
is performed.
The idea behind METRADE is that an accurate prediction on the relations among
conditions should not disregard a multi-omic model to associate conditions to a phenotypic
outcome in a set of objective spaces; indeed, a multi-omic inference cannot be performed
by looking only at the gene expression profiles, but requires a mapping to the phenotype
that estimates the actual effect of each condition on the bacterial physiology. Unlike
GDMO, METRADE searches in the continuous space of gene expression levels. Therefore,
it is not limited to knockout analysis, but also includes gene overexpression and partial
knockdown. While the applications of METRADE shown in this chapter are on two-
dimensional objective spaces, METRADE can be applied to spaces of more than two
dimensions. In Section 3.8, we validate METRADE against a publicly available phenomics
dataset of E. coli, and against experiments performed on cultures of Corynebacterium
glutamicum and Saccharomyces cerevisiae.
To the best of our knowledge, very few approaches have been developed to take into
account non-discretized gene expression levels in constraint-based models [23]. The key
advantage of a continuous genotype-metabotype map is that one can reverse it, obtaining
an enviromics map, which allows identifying the environmental factors leading to a pre-
specified metabotype. For all we know, no prior studies have accounted for codons and
combined Pareto-optimization with real-valued gene expression levels, codon usage bias,
and component analysis. This paves the way towards predicting and optimizing bacterial
adaptability across conditions and over time. METRADE is freely available as a toolbox
extension of COBRA 2.0 [143], the most widely used MATLAB toolbox to perform FBA.
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Fig. 3.1 Pipeline of METRADE (MEtabolic and TRanscriptomics ADaptation Esti-
mator). Part I (panels 1-3). The response to environmental conditions (1) in which E. coli
is grown (e.g., low or high glucose, aerobic or anaerobic, pH changes, antibiotics, heat
shock) is measured through Affymetrix Antisense2 microarray expression profiling (2).
To evaluate the environmental conditions and detect their community structure, we derive
a multi-omic model (3) of the E. coli metabolism, taking into account gene expression
(Section 3.2) and codon usage (Section 3.4).
Part II (panels 4,5). (4) The multi-omic model enables us to account for multiple growth
conditions and temporal multi-objective evolution towards the production of selected
metabolites through the Pareto front (Section 3.3). It is also able to associate each environ-
mental condition with a single point in a multidimensional condition phase-space (Section
3.5). The adaptability to one condition is given by the time evolution of the bacterial
genome, which can be estimated by the hypervolume indicator (Section 3.6). (5) A set of
techniques can be applied to the multi-omic model with the aim of analyzing the adaptability
to experimental conditions. We apply principal component analysis (5a) to the condition
space in order to investigate the directions with largest variance (Section 3.7). A more
detailed analysis of the condition space can be obtained through a distance matrix built on
the condition phase-space (5b), and a spectral method for community detection to infer
similarities among growth conditions (5c) [11].
47
3.2 A novel method for integration and optimization of gene expression in FBA
3.2 A novel method for integration and optimization of
gene expression in FBA
Each reaction in an FBA model depends on a single gene set, represented by a set of genes
linked by AND/OR operators. For instance, when a gene set is composed of two genes in
an AND relation, both are necessary to catalyze the corresponding reaction, and knocking
out only one gene is sufficient to knock out the reaction. In this case, the gene set represents
an enzymatic complex. Conversely, when a gene set is composed of two genes in an OR
relation, the two genes synthesize for isozymes, which differ in the amino acid sequence,
but catalyze the same reaction. Therefore, one gene is sufficient to catalyze the reaction,
and all the genes must be knocked out in order to knock out the reaction.
With the aim of overcoming the limitations offered by the Boolean knockout approach,
we need to formalize the AND/OR relation between genes using a real-valued map that
enables us to define a variable called “gene set expression” as function of the gene expression.
Let x ji , i= 1, . . . , p, be the gene expression levels of the genes s
j
i , i= 1, . . . , p, and let ∧is(1)i
and ∨is(2)i , i = 1, . . . , p, be two basic gene sets modeling an enzymatic complex and an
isozyme respectively. We adopt the following map τ between a gene set and its expression:∧
i=1,...,p
s(1)i
τ7−→ min
i=1,...,p
{x(1)i }, (3.1)∨
i=1,...,p
s(2)i
τ7−→ max
i=1,...,p
{x(2)i }. (3.2)
Specifically, the expression level of an enzymatic complex, which needs all its genes to
work properly, is constrained to be equal to the lowest of the expression levels of its genes.
Conversely, the expression of an isozyme, which needs at least one of its genes, is the largest
of the expression levels of its genes. The bounds of a reaction catalyzed by an enzymatic
complex will be function of the minimum expression level of its genes, while the bounds
of a reaction catalyzed by isozymes will be function of the maximum expression level of
its genes. Nested gene sets are treated with the same methodology, i.e., applying (3.1) and
(3.2) recursively.
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We run the model to find the distribution of fluxes that optimizes multiple metabolic
markers (e.g., natural and synthetic objectives). As the bounds of the fluxes depend on the
gene expression, we define the following bilevel linear program:
max gᵀv
such that max f ᵀv
such that Sv = 0
vi ≥ vLi ·h(yi)
vi ≤ vUi ·h(yi)
(3.3)
where f and g are n-dimensional arrays of weights associated with the first and second
objective that will be selected for the optimization, and indicate how much the reaction
fluxes in the vector v contribute to the objective function. vLi and v
U
i are the minimum and
maximum flux of the wild-type configuration of the model. In the present dissertation,
f and g are Boolean vectors. For instance, f j = 1 and gk = 1 if and only if the fluxes v j
and vk have to be maximized as first and second objective respectively. In order to define
the function h, let yi be the gene set expression of the ith gene set, responsible for the ith
reaction of the model. To map the gene set expression value into a specific condition of the
model, we use the following piecewise multiplicative function:
h(yi) =
(1+ |log(yi)|)sgn(yi−1) if yi ∈ R+ \{1}1 if yi = 1 (3.4)
where sgn(yi−1) = (yi−1)/ |yi−1|.
In the FBA model, we replace the minimum and maximum flux of the ith reaction with
vLi ·h(yi) and vUi ·h(yi) respectively, where vLi and vUi are the minimum and maximum flux of
the wild-type configuration of the model. This choice is consistent with the fact that all the
gene expression values in various conditions are relative to those of the wild-type bacterium.
The gene set expression level is transformed by the logarithmic function h(·) so as to avoid
that the genetic algorithm that we will use to perform the multi-objective optimization is
driven towards high and unfeasible values of gene expression. This approach is in keeping
with the “lazy step function” found in bacteria, yeast and human cells. According to this
function, the mRNA levels are good indicators for the abundance of a protein (especially
when averaging across populations), while post-transcriptional, post-translational and
degradative regulations may fine-tune the protein abundance through miRNA [166].
On large samples, the correlation between mRNA level and protein abundance has
been shown to be more evident with principal component analyses [72] and especially for
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highly expressed genes, where the amount of noise is small and the correlation is high
[51, 105, 169]. Overall, in single living organisms, the correlation is good except when
proteins are long lasting and mRNA short lived. Furthermore, quantitative proteomics and
transcriptome profiling (RNA-seq) seem to prove that there is high association between
mRNA and protein levels, indicating that mRNA measures can be used as approximation
for protein abundance [48, 71, 108]. In METRADE, we link the gene expression profiles
with the FBA fluxes of the associated reactions in E. coli defining a real-valued adjustable
map. Given that protein synthesis is an outcome of the expression of genes coding for
protein segments, we link the gene expression values to the flux of the reactions controlled
by the proteins coded by those genes. We share with E-Flux the approach of modifying
the upper and lower bound of the reactions according to the gene expression value of the
associated genes [42]. However, we use a logarithmic map to relate transcript level to flux
bounds.
Due to the lack of direct correspondence between flux rate and transcript level (transla-
tion, degradation, and post-translational modifications are ignored), differential expression
levels are adopted here. Therefore, the expression profile of a “wild-type bacterium” is
considered as a control condition, and is associated with the original genome-scale model
with unchanged lower and upper bounds.
While h is adjustable depending on the cell type or bacterial strain, we suggest a loga-
rithmic map for a number of reasons. Specifically, the increase in the protein synthesis rate
is fast with increasing mRNA abundance, but slower for large values of mRNA abundance
[62]. Furthermore, adopting a logarithmic function in combination with the optimization
algorithm avoids setting unrealistically high values of measured gene expression levels,
which would be converted into weak constraints if using, e.g., a linear map. A key advan-
tage of our map h is that it is roughly linear in the neighborhood of 1 (the wild-type gene
expression level); this property models the experimental findings of high correlation and
a roughly linear relation between gene expression and enzyme activity for the wild-type
E. coli [128, 147]. Finally, several empirical evidences support our assumption [71, 125].
We remark that we use the logarithmic map to set constraints for the metabolic model, then
we solve the linear program (3.3) to find the flux distribution.
A reaction whose related genes are under-expressed, is impaired through narrowing
its flux bounds according to the related gene expression values, rather than completely
removed from the model as done in the common approaches integrating genomics and
FBA. Analogously, if those genes are over-expressed, the domain of the reaction flux is
automatically enlarged, rather than left unchanged. The idea behind the integration of gene
expression implemented in METRADE is presented in Fig. 3.2. We assume that the genetic
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Fig. 3.2 Flowchart of the integration of gene expression implemented in METRADE.
Each reaction of the metabolic network constituting the FBA model depends on a gene
set. Therefore, the flux of each reaction depends on the corresponding gene set expression,
computed taking into account the expression of the genes in the gene set, and their AND/OR
relation. The real-valued function h converts gene set expression values into bounds for the
bilevel FBA model. As a result, the decision variables for the multi-objective optimization
are the gene expression values.
level is slower than the metabolic one, and therefore the steady state is reached faster than
the variation of enzyme concentrations due to changes in the gene expression profile [153].
The E. coli metabolism is assumed to be at a steady state that relies on environmental
factors and is reached quickly if compared to the variation of enzyme concentrations due to
changes in the gene expression profile. Since the gene expression data are used as indicators
for the activity of the associated reactions in the model, each gene expression profile is
associated with a point in a multidimensional objective space.
Note that the outer maximization problem in (3.3) is subject to the inner one. More
specifically, the inner maximization finds the distributions of flux in the network such that
the growth rate (first objective) is maximized. In the outer maximization, all the unregulated
fluxes are then distributed such that the second objective is maximized. The lower and upper
bounds of the ith flux vi depend on the expression of the genes involved in the ith reaction.
The bilevel problem is finally converted to a single-level problem, and solved using the
GLPK solver. It is straightforward to check that all the approaches based on Boolean gene
knockouts become a particular case of METRADE, being h(yi)
yi→0−→ 0 and h(1) = 1.
3.3 Multi-objective optimization of multi-omic models
We optimize the metabolic model through a multi-objective evolutionary algorithm, reaching
an optimal configuration, according to the definitions in Section 1.4. In the Boolean
evolutionary approach GDMO (Section 2.1), each individual is a strain represented by
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a binary variable set representing the knockout strategy of gene sets [44]. Conversely,
in METRADE the individuals are arrays of real values, each of which represents the
expression level of a gene. We refer to these real-valued arrays as gene expression arrays.
Through the function h(·), the gene expression arrays have a continuous effect on the FBA
model, rather than only an on/off effect on reactions as in the Boolean approaches. Therefore,
we are able to simulate cases where a lowly-expressed gene does not completely turn off
the corresponding reaction (partial knockdown) and, analogously, a highly-expressed gene
is able to increase the upper limit of the reaction flux (overexpression).
For the multi-objective optimization, we develop a parallel genetic algorithm (PGA)
inspired by NSGA-II [52]. In our approach, both mutation and cross-over are allowed. A
mutation represents a change in one or more gene expression levels, and proves useful to
avoid the premature convergence to local optima. A cross-over consists of merging two
parents to generate a child, exploiting the principle that two good solutions are able to
generate a better solution. After generating an offspring population, a new population is
formed selecting the best individuals from the parents of the previous generation and the
current offspring. The technique of considering the best individuals of the old population
is called elitism and ensures that good individuals are not lost during the evolution. The
new population can then be subjected to a new round of mutation, crossover and selection.
Our PGA is parallel, easy to use, and suited for black-box analysis. For each generation of
the algorithm, we provide the Pareto optimal solutions, in order to evaluate the evolution
of the Pareto front. This loop is repeated until the solutions set does not improve, or
until an individual with a desired phenotype is achieved. The number of generations and
the cardinality of the population are parameters chosen by the user. In our experiments
we consider 1500 populations of 1000 individuals each, in order to ensure an extensive
exploration of the objective space. Each point of the Pareto front is not merely a specific
optimal model in the objective space, but also a gene expression array representing a specific
genotype in the variable space. All the computations have been carried out on a machine
with two 2.66 GHz 6-Core Intel Xeon processors and 64 GB of RAM.
We test METRADE on the iJO1366 E. coli metabolic reconstruction [119], consisting
of three compartments (cytoplasm, periplasm and extracellular space), 1805 metabolites,
1366 genes, and 2583 reactions (including exchange and biomass reactions). The flux
through the biomass reaction represents the rate at which the bacterium produces those
metabolites necessary for its growth (e.g., amino acids, lipids, cofactors and proteins). The
stoichiometry of the biomass reaction is scaled so that its flux rate equals the exponential
growth rate of the bacterium. The objective functions taken into account are the fluxes
representing the production of acetate, succinate, 1,2-propanediol and biomass (the major
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players in synthetic biology of E. coli). We start from a gene expression array equivalent to
the case in which all the bounds of the fluxes are left unchanged with respect to the initial
model (wild-type bacterium). In Fig. 3.3 we show the regions of objective space discovered
by the genetic algorithm from the first to the last generation for anaerobic and aerobic
conditions. The PGA starts from an array of gene expression that, when translated into flux
bounds, gives the default lower and upper bound of the initial model. As a case study, we
maximize the acetate and biomass production, and succinate and biomass production. As
mentioned in Chapter 2, both acetate and succinate are key molecules in biotechnology,
with multiple industrial applications [131].
In the anaerobic case, we also apply the same approach with a Gaussian noise added
to the initial values of the decision variables in order to avoid getting trapped in local
maxima. Interestingly, in the acetate-biomass case (Fig. 3.3e), the area under the Pareto
front is larger, and the number of optimal solutions is increased with respect to the case
where no perturbations are applied. Furthermore, the Pareto front exhibits a curvature,
although the extreme points (maximum acetate and maximum biomass) are conserved. In
the succinate-biomass case, the same initial perturbation allows for a better coverage of
the two-dimensional objective space (Fig. 3.3f), with a new extreme point of maximum
succinate.
Without oxygen, the E. coli is able to grow with a maximum rate of 1.04 h−1, compared
to 1.24 h−1 reached in presence of oxygen. Nevertheless, the production of succinate in
anaerobic conditions is increased, especially when searching the optimal gene expression
profile starting from the initial array with added noise. The gene expression profiles opti-
mized towards maximum succinate production yields 17.14 mmol h−1 gDW−1 (millimoles
per gram of dry weight per hour) but no biomass. A more interesting solution is 6.38 mmol
h−1 gDW−1 of succinate with 0.18 h−1 of biomass. The maximum amount of biomass that
can be achieved with a nonzero succinate production (0.34 mmol h−1 gDW−1) is 1.04 h−1.
A similar pattern emerges when maximizing acetate production and biomass. Specifi-
cally, in aerobic conditions, the maximum biomass is 1.26 h−1 and the maximum acetate is
15.56 mmol h−1 gDW−1 (not taking into account the extreme solution with no biomass).
Conversely, in anaerobic conditions, the maximum biomass is 1.04 h−1 (with 4.36 mmol
h−1 gDW−1 of acetate production), while the maximum acetate is 19.86 mmol h−1 gDW−1.
Interestingly, both conditions share the same intermediate trade-off points with acetate
production between 4.36 and 15.56 mmol h−1 gDW−1.
The main difference between anaerobic and aerobic conditions, especially when max-
imizing succinate as synthetic objective, is the amount of succinate produced with an
acceptable growth rate. The succinate in the cytoplasm takes part in 26 metabolic reactions.
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When no oxygen is imported, only five reactions are activated: succinate is a product
of Succinyl-diaminopimelate desuccinylase, O-succinylhomoserine lyase, and Fumarate
depended dihydroorotate, and a reactant of Succinate dehydrogenase and Succinyl-CoA
synthetase. Ten transport fluxes are responsible for transferring succinate in the periplasm
and in the extracellular space. In anaerobic conditions, the transfer is performed by proton
antiport.
3.4 Integration and optimization of codon usage in FBA
Manipulating and co-optimizing the gene expression and the codon usage of a bacterium
enables us to design strategies for overproduction of relevant compounds, from therapeutic
and industrial standpoints (e.g., amino acids and alcohols) [111]. This is of key importance
when aiming at producing desired products through biosustainable processes. The idea
underlying our approach is that even if two gene expression profiles are identical, the
organism has the possibility to optimize its codon usage with small variations, allowing a
co-optimization for a given set of objectives.
To account for the codon usage frequency in the translation process, we analyze a
simplified situation where genes are made up of a slow codon c(1) and a fast codon c(2),
read by two tRNAs with abundance a1 and a2 respectively [16, 93]. Let us denote by c
(1)
i
and c(2)i the slow and fast codon usage of the ith gene. In each gene gi, c
(1)
i and c
(2)
i can
be used independently from one another. Since the total usage of a codon by all the genes
depends on the abundance a of the corresponding tRNA, we set new constraints in our
model:
∑
i
c( j)i = a j, (3.5)
where j = 1,2 ranges over the codons, and i ranges over the genes.
In order to optimize the codon bias, we let the codon usage values c( j)i evolve using the
PGA, and the constraints (3.5) hold at each generation of the algorithm. Then, the codon
usage bias influences the rate of protein synthesis, and therefore the related reaction flux.
If the fast codon is used more than the slow one, the translation process becomes faster.
The production of the protein will be boosted by fast codons also because more ribosomes
could operate on the same mRNA. To achieve this, the value yi representing the gene set
expression in METRADE is modified accordingly, thus obtaining a final variable zi that
includes the effects of the gene expression and the codon usage bias:
zi = yi−αic(1)i +βic(2)i , (3.6)
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Fig. 3.3 Pareto front produced by METRADE when maximizing succinate, acetate
and biomass production. On low succinate, slight variations of succinate flux cause
step variations of biomass (plot (f)). The initial perturbation (e,f) is applied in anaerobic
conditions on the first candidate strains and improves the convergence of the algorithm, thus
permitting to avoid local maxima and to increase the coverage of the objective space. As a
result, we discover a new area not explored by the algorithm applied in (c,d), including a
new maximum for the succinate production. Solutions are denoted by progressively warmer
colors according to the time step of the PGA in which they have been generated adaptively
from the starting point.
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where c( j)i are the values representing the codon usage (variables for the multi-objective
optimization), while αi and βi are multiplicative constants that can be used to increase the
effect of the slow codon with respect to the fast one, or vice versa. We set αi = βi = 50, ∀i,
so as to obtain a noticeable effect of the codon usage even with a small number of generations
from the optimization algorithm (with different values of αi and βi we obtained different
speed of convergence but the same shape of Pareto front). These two parameters and the
equation (3.6) can be used to adjust the strength of the codon bias on the overall protein
synthesis. As in Section 3.3, the multi-objective optimization algorithm drives a bilevel
linear program that computes the flux distribution, and two of these fluxes are considered as
the objective functions of the optimization algorithm. Here we compute the flux distribution
through the following bilevel program:
max gᵀv
such that max f ᵀv
such that Sv = 0
vi ≥ vLi ·h(zi)
vi ≤ vUi ·h(zi)
(3.7)
where f , g, vLi , and v
U
i have the same role as in (3.3), while h is defined in (3.4).
In this formulation, we do not take into account clusters and positions of rare codons.
The definition (3.6) models the effect that the codon usage bias has on the final expression,
and mimics the fact that the codon usage strongly affects translation rate and protein
production [132]. In this regard, it has been recently shown that a change in the synonymous
codon usage in an N-terminal peptide may result in an increase in the protein abundance up
to 60-fold [69].
Once a point in the objective space has been found by METRADE starting from the
associated gene set expression profile yi, flexible codon usage
(
c(1)i ,c
(2)
i
)
allows exploring
the neighborhood of that point, using the Pareto front and the optimality principle to
seek solutions. In Fig. 3.4, we present the optimization of acetate, succinate and biomass
production starting from a wild-type E. coli strain and using the codon usage values as
decision variables, i.e., as input variables constituting the individuals in the multi-objective
optimization process. In the acetate-biomass optimization, the acetate production increases
linearly with decreasing biomass. In the succinate-biomass optimization, a slight change in
the codon usage towards an increased succinate production causes the growth rate to drop
from 1.04 h−1 to 0.60 h−1. A further drop (0.39 h−1) allows producing 7.45 h−1 gDW−1
of succinate.
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Fig. 3.4 Optimization of codon usage for maximization of acetate and biomass produc-
tion (a), and succinate and biomass production (b) starting from a wild-type E. coli.
The Pareto front is obtained by applying our multi-objective optimization routine to the
variables representing the codon usage, treated as input variables. We let METRADE
run for 50 generations, which a preliminary analysis proved sufficient to obtain a Pareto
front spanning the objective space. We denote solutions by progressively lighter colors
depending on the generation in which they have been found. The red circle corresponds to
a fixed array of gene expression levels (a wild-type E. coli strain).
While gene expression maps the external or internal condition of the organism at the
transcription level, the codon usage maps quick alterations to fine tune the amount of protein
produced at the translation level. A possible application of the gene expression and codon
usage co-optimization is to evaluate the ratio between the gene expression and the codon
usage variations with respect to a given non-optimal condition. This ratio can be computed
for every pathway and exploited to highlight the difference among pathways. As a result, the
Pareto front becomes a promising tool to investigate a model from a multi-omic standpoint.
3.5 Mapping genotype-phenotype associations to multidi-
mensional objective spaces
Another useful feature of METRADE is the possibility of mapping a gene expression
microarray profile directly to a bidimensional space of objective functions (e.g., acetate,
biomass and succinate). Compared to Boolean associations between gene presence/absence
and reaction activation/inactivation, this feature is extremely useful in the sense that it
allows continuous modulation of the output, and even the effect of small variations of
gene expression level is captured, and could have a significant impact on the metabolism.
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Here we use a compendium of 466 E. coli Affymetrix Antisense2 microarray expression
profiles by Faith et al. [58]. The dataset includes data collected in different media and
different conditions, such as pH changes, antibiotics, heat shock, varying glucose and
oxygen concentrations.
The idea behind our approach is that each condition yields a particular gene expression
profile, which we convert into constraints for the FBA model in order to evaluate the
condition-specific metabolic response. After defining the synthetic and natural objectives,
we run the model and for each condition we obtain a point in the selected objective space.
The model is run with an oxygen and glucose intake rate depending on the oxygen and
glucose of the condition in which the bacterium was grown.
We assume that the genetic level is slower than the metabolic one, and therefore the
steady state is reached faster than the variation of enzyme concentrations due to changes in
the gene expression profile [153]. As a result, the metabolism is assumed to be always at a
steady state that depends on the environmental factors. In this way, the gene expression data
are used as estimator of the activity of the corresponding reaction in the model, and we are
able to associate a given gene expression profile with a single point in a multidimensional
and user-defined objective space. In this section, we consider the objective space of
biomass-acetate flux rates, and the objective space of biomass-succinate flux rates.
Importantly, we take into account that a gene whose expression level is only slightly
varied across conditions is a key gene for the organism [107]. We assume that the importance
of a gene - and therefore the robustness of the reaction fluxes for which that gene is
responsible - is inversely proportional to its variance across all the experimental conditions.
Essential genes are in fact more tightly regulated and evolve slowly, as a high variance of
gene expression level of essential genes would affect all the downstream genes and is more
likely to be less tolerated in a large interaction network [66, 122]. For instance, essential
genes in the metabolic network are those coding for an enzyme controlling a reaction which
is upstream of many others (e.g., upstream of the TCA cycle).
To map conditions to the objective space, we solve the following bilevel problem:
max gᵀv
such that max f ᵀv
such that Sv = 0
vi ≥ vLi · k(yi)
vi ≤ vUi · k(yi)
(3.8)
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with
k(yi) =
[
1+
γ
σ2i
|log(yi)|
]sgn(yi−1)
, (3.9)
where σ2i is the variance of the gene set responsible for the ith reaction, and γ is a weight
for the variance. The parameter γ represents the weight attributed to the variance as an
indicator of the importance of a gene, and determines the effect of the gene expression
values on the final reaction rates. The variances σ2i of the gene sets are computed from the
variances of the genes across the conditions in the dataset, following the same rules defined
to map the gene expressions to the gene set expressions (Equations (3.1) and (3.2)).
As case-studies for this method, we choose the acetate-biomass space (Fig. 3.5a) and
the succinate-biomass space (Fig. 3.5b). For increasing γ , the E. coli is able to move
towards the production of the second objective (acetate or succinate) rather than the natural
objective (biomass). By increasing the parameter γ we increase this effect, therefore even
two experimental conditions with slight differences in the gene expression profiles are
mapped to different points in the objective space. The map from genes to metabolism is
robust with respect to perturbations of γ , while large perturbations of γ (orders of magnitude)
increase the sensitivity of the metabolism to the different environmental conditions. For
the succinate-biomass case, the best trade-off is reached when γ = 104: the best gene
expression profiles are able to produce 21.06 and 13.87 mmol h−1 gDW−1 of succinate
with a biomass of 1.13 and 1.45 h−1 respectively. Nevertheless, an excessive role attributed
to gene expression as a multiplicative factor for the flux bounds (e.g., γ = 105 in the
succinate-biomass space) leads to a reduced production of biomass (0.85 h−1 maximum),
although providing remarkably high values of synthetic flux rates (up to 34.67 mmol h−1
gDW−1). Conversely, for the acetate-biomass case, increasing γ improves the area of
the space covered, but does not provide remarkable new regions of increased acetate and
biomass yield. We also increased the order of magnitude of γ over 104, but we did not
notice significant changes with respect to γ = 104.
In Fig. 3.6, we test this approach on the Colombos 2.0 compendium of microarray data
[112], which includes data for 2369 measured conditions. In both the objective spaces
selected, the plot identifies the subspace where the bacterium operates. Specifically, when
maximizing for acetate and biomass production, E. coli shows greater variability and
different outcomes in different conditions; the conditions are mapped to points that cover
most of the objective space. Conversely, when maximizing for succinate and biomass
production, only few conditions are able to ensure succinate production. Interestingly,
one of the two best working conditions in the succinate-biomass space is anaerobic. The
most interesting condition yields 19.66 mmol h−1 gDW−1 of acetate flux with 0.48 h−1 of
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Fig. 3.5 The 466 profiles of gene expression (each associated with one condition) po-
sitioned in the two-dimensional space acetate-biomass (a) and succinate-biomass (b).
Each point is obtained starting from a gene expression profile, converting it into a gene
set expression profile y using (3.1)-(3.2), and finally applying (3.8) and considering only
the fluxes associated with the objectives on the axes of the plots above. The parameter γ
quantifies the effect of the gene expression values on the final reaction rates.
biomass. Only one anaerobic condition is able to ensure high biomass. In the succinate-
biomass space most experimental conditions yield low value of succinate and biomass, but
the best anaerobic condition gives 8.85 mmol h−1 gDW−1 of succinate flux with 0.66 h−1
of biomass.
3.6 The hypervolume indicator as a measure of adapta-
tion over time
A measure for the volume of the dominated portion of the objective space is the hypervolume
indicator. The hypervolume allows comparing different Pareto sets and evaluating the
evolution of a Pareto set over time. In our two-objective spaces, since our aim is the
maximization of the objectives, we choose O = (0,0) as a reference point. Intuitively, the
reference point determines if the area of the objective space where the algorithm performs
its search is above or below the Pareto front. Let the subset X ⊂ R2 represent the Pareto
front. We define the hypervolume indicator as the Lebesgue measure of the space dominated
by X with respect to the reference point O, namely the space between X and O:
IH(X) =
∫
R2
1H(X ,O)(z)dz, (3.10)
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Fig. 3.6 The 2369 Colombos gene expression microarray profiles mapped to a bidi-
mensional space of objective functions acetate-biomass (a) and succinate-biomass (b).
Among the 2369 conditions (obtained with different pH, antibiotics, heat shock, glucose
concentrations), 72 conditions are anaerobic. Each gene expression profile is translated
into flux bounds and gives the lower and upper bound of the model using (3.9); then, the
bilevel problem (3.8) is solved with acetate-biomass and succinate-biomass as objectives,
thus obtaining a point in each of the two objective spaces.
where H is the set of points dominated by the Pareto front X . 1H(X ,O) indicates the charac-
teristic function and has value 1 at points of H(X ,O) and 0 at points of R2 \H(X ,O). When
the number of Pareto solutions is finite, i.e., X = {(p1,q1), . . . ,(pn,qn)}, the hypervolume
equals
IH(X) =
n
∑
i=1
qi(pi− pi−1), (3.11)
where for convenience of notation we set p0 = 0. Given the set of Pareto optimal solutions,
the hypervolume can be exploited in the decision-making process, e.g., through the selection
of a hypervolume-maximizing subset of the Pareto-optimal set.
During the growth process of a bacterial population, the short term evolution of a single
strain ranges from a wild-type configuration towards an optimized configuration where
two objectives are taken into account. In order to gain insights into the evolution of an
E. coli strain on a short temporal scale, and to provide a more accurate description of its
order of growth, we analyze the dynamics of the strain on a bidimensional objective space
consisting of biomass and 1,2-propanediol production (Fig. 3.7a). Different strains may
evolve on large temporal scales on the same bidimensional space, starting from different
initial points. Here we take into account the initial point that refers to the wild-type E. coli
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K-12 MG1655 grown on morpholinepropanesulfonic acid (MOPS) minimal medium, with
anaerobic aeration, culture temperature of 37◦C and 11 mM of glucose.
In order to investigate the evolving tradeoff in the objective space, we use the Pareto
front as a measure for the evolution of the strain. We remark that the Pareto front shows
the metabolic tradeoff between two objectives in the objective space. In METRADE,
each point of the Pareto front represents the objective vector (flux rates in the objective
space) corresponding to an optimal array of gene expression values (in the search space).
Specifically, we quantify the evolution by computing the hypervolume indicator (and its
first derivative) of ten Pareto fronts obtained during the evolutionary process of the PGA
underlying METRADE. The hypervolume is an indicator for the size of the space covered
by the Pareto front in a multidimensional objective space. Among its properties, it is
strictly monotonic with respect to strict Pareto dominance. Therefore, the ideal Pareto front,
reached only asymptotically when the number of populations generated approaches infinity,
achieves the maximum hypervolume available for the system [15].
We propose the hypervolume as a proxy for the versatility of an organism and for its
ability to ensure simultaneous production of multiple chemicals. An assumption of most
FBA models is that a wild-type bacterium is specialized towards the production of biomass
only, therefore lying on one axis of the multidimensional space, i.e., with null hypervolume.
In Fig. 3.7a, the PGA adaptively finds the trade-off for the K-12 MG1655 E. coli that
moves on the objective space towards maximization of 1,2-propanediol production and
growth rate. We captured ten snapshots of the evolution at ten equally distributed time steps
(i.e., every 150 populations generated by the PGA). During the evolution towards multiple
objectives, the bacterium moves and covers increasing portions of the objective space. The
size of the space covered can be measured with the hypervolume indicator, while the speed
of evolution can be associated with the hypervolume first derivative. In Fig. 3.7b, we plot
the evolution of the hypervolume indicator over time. At each time step, we compute the
hypervolume of the corresponding Pareto front using Eq. (3.11), after sorting its points
(pi,qi) in ascending order of p. The initial growth ends after two time steps, and starts
again after four time steps, decreasing at the final step. The hypervolume shows a plateau
between two phases of increase. The derivative of the hypervolume indicator highlights
alternating periods of slow and fast evolution that could be associated with the feast and
famine growth phases of the bacterial population.
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Fig. 3.7 Temporal evolution of E. coli K-12 MG1655 grown on MOPS minimal
medium when optimizing concurrently towards 1,2-propanediol production and
growth rate using METRADE. (a) Evolving metabolic tradeoff towards the optimal
production rates. The figure shows the progression of the Pareto front during the evolution
of the algorithm, at 10 time steps. (b) Hypervolume indicator over time. We evaluate the
hypervolume of the Pareto front at each of the 10 steps, using Eq. (3.11), after sorting the
points (pi,qi) of the Pareto front in ascending order of p. The discrete time points have
been interpolated with a cubic piecewise polynomial.
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3.7 Principal component analysis on multi-objective spaces
reveals genes-to-protein effect
In the objective spaces obtained when mapping the gene expression profiles to the target
metabolites, we perform a principal component analysis (PCA) based on the singular value
decomposition (SVD) of the data obtained by mapping each gene expression condition
on the objective space. We obtain Fig. 3.8 starting from Fig. 3.5a, and Fig. 3.9 starting
from Fig. 3.5b. This is equivalent to finding the system of axes in which the covariance
matrix is diagonal. The PCA is often used to detect redundancy of information due to the
fact that group of variables may vary together, and therefore can be replaced by a single
variable. This is achieved through the definition of new variables as linear combinations of
the original variables. The new variables, called principal components, are orthogonal to
each other (so as to avoid redundancy) and represent an orthogonal basis. The simplification
is achieved by discarding those components that explain little variance in the data, i.e., the
components corresponding to the smallest eigenvalues of the covariance matrix.
We apply the PCA to the points representing the E. coli conditions mapped to the
bidimensional objective space. The eigenvalues l1 and l2 of the covariance matrix indicate
the variance explained by the first and second principal components respectively. The
eigenvector with the largest eigenvalue l1 represents the direction of maximal variation of
the points in the objective space. Combining PCA and the map between gene expression
profiles and multidimensional objective spaces allows assessing the relative impact of γ on
the position of each gene expression profile in the objective space. As we also introduced in
Section 3.5, the choice of this parameter merits further experimental investigation (e.g., with
a parameter optimization algorithm). More specifically, our results show that the parameter
γ , which represents the effect of the gene expression on the final reaction bounds of the FBA
model, has a direct effect on the direction of the maximum variance, as shown in Table 3.1.
In the application shown in Figs. 3.8 and 3.9, PCA has been used to quantify the
effect of the parameter γ in our method. We note that, while in two dimensions PCA can
be generally avoided and in some cases replaced by visual inspection, the combination
between METRADE and PCA is useful when optimizing for more than two objectives.
Using PCA, the dimensionality of the phase-space of conditions can be reduced by looking
at the directions of “phenotypic” maximum variance across a given set of environmental
conditions.
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Fig. 3.8 PCA in the acetate-biomass objective space. The two principal components are
computed using the principal component analysis on the centered data (x−µx,y−µy), but
are plotted on the original data. The slope of the first principal component (i.e., the direction
of maximum variance of the data), depends on the parameter γ , the multiplicative factor
that influences the effect of the gene expression data on the upper and lower bounds of the
reaction fluxes in the FBA model. The second principal component is always perpendicular
to the first component (not highlighted in these plots due to different scales used).
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Fig. 3.9 PCA in the succinate-biomass objective space. The plots have been obtained
with the method described in Fig. 3.8. With respect to the first two cases, the direction of
the first principal component in the last two cases is remarkably different.
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γ pc1 pc2 l1 l2
1 (0.9997,0.0247) (0.0247,−0.9997) 12.9026 0.0460
100 (0.9997,0.0251) (0.0251,−0.9997) 12.7476 0.0463
500 (0.9996,0.0299) (0.0299,−0.9996) 9.5999 0.0462
1000 (0.9999,0.0161) (0.0161,−0.9999) 11.2712 0.0597
γ pc1 pc2 l1 l2
102 (9.7072 ·10−14,−1) (−1,−9.7072 ·10−14) 0.0542 4.1806 ·10−25
103 (−8.6034 ·10−13,1) (−1,−8.6034 ·10−13) 0.0626 1.5392 ·10−23
104 (1,−2.8217 ·10−3) (−2.8217 ·10−3,−1) 2.1323 0.1267
105 (−1,−3.2925 ·10−4) (3.2925 ·10−4,−1) 37.6676 0.0121
Table 3.1 Values of γ , the principal component coefficients pc1 and pc2 (expressed as pair
(a,b) of the line ax+ by = 0), and the principal component variances l1 and l2 (i.e., the
eigenvalues of the covariance matrix) of the gene expression data in the acetate-biomass
objective space (top) and succinate-biomass objective space (bottom). The eigenvalues
l1 and l2 indicate the variance explained by the first and second principal components
respectively. The eigenvector with the largest eigenvalue l1 represents the direction of
maximal variation of the points in the objective space.
3.8 Approaches towards experimental validation of ME-
TRADE predictions
In silico predictions of flux distributions may be validated in vivo through biological
experiments aimed at measuring the flux rates of a set of biochemical reactions. The most
common approach for measuring flux rates is called metabolic flux analysis (MFA). MFA
uses carbon 13C-labeled substrates to quantify intracellular fluxes in the central metabolism
only [180], although an attempt to extend MFA to genome-scale models has recently
been published and assessed [70]. An approach that uses 13C labeling data to constrain
metabolic models has been proposed by Martín et al. [110]. MFA is used in the study
of microbial physiology, but currently not in mammalian cells and plants due to more
complex metabolic networks and growth media where applying MFA is more challenging.
Furthermore, carrying out a carbon-labeling experiment is not simple and requires a number
of experimental steps [31].
An easier way to partially validate FBA-based flux distributions is the measurement
of the growth rate, or the rate of production of a specific compound in a cell culture. The
experimental values are then compared with the predicted values to check the correctness
of the FBA-based method used. At this stage, wrong predictions are not necessarily due to
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the method, and may also lead to discovery of gaps in the metabolic model (e.g., missing
genes, missing reactions, or incomplete gene-protein-reaction associations).
In this section we compare the results obtained by our method with a publicly available
set of experiments performed on Escherichia coli, where the growth rate was measured,
and with the experimental results on Corynebacterium glutamicum and Saccharomyces
cerevisiae (yeast) provided by Dr J. Dias, Dr D. Dikicioglu and Prof S. Oliver, from the
Department of Biochemistry, University of Cambridge, UK. For C. glutamicum, we are able
to compare our predictions with the measured value of flux rate for succinate production. For
S. cerevisiae, we apply METRADE on four microarray profiles mapped to the ATP-biomass
and D-glucose-glycerol objective spaces, and we obtain insights into the flux distributions,
which were subsequently confirmed by our collaborators. We would like to acknowledge
them for the permission to include in this dissertation some of the results we obtained
starting from their experimental data on S. cerevisiae and C. glutamicum. The collaboration
is still ongoing and we plan to obtain and validate further predictions of metabolic flux rates
in yeast and E. coli.
3.8.1 Case study I: Escherichia coli
To validate METRADE on E. coli, we use the phenomics dataset by Hui et al. [78]. The
compendium contains 14 expression profiles in different growth conditions, with measured
growth rates between 0.28 and 1.04 h−1. The different conditions were obtained with: (i)
titrated catabolic flux through controlled inducible expression of the lacY gene; (ii) titrated
anabolic flux through controlled expression of GOGAT; (iii) inhibition of protein synthesis
with an antibiotic (chloramphenicol). Overall, we obtain remarkable results in predicting the
growth rate from the expression profile associated with each condition. On the full dataset,
we obtain a strong correlation between predicted and measured growth rates (Pearson’s
r = 0.81, p-value= 4.38 ·10−4, and Spearman’s ρ = 0.78, p-value= 9.21 ·10−4). The best
results are obtained with the subset of conditions representing inhibited protein synthesis by
supplying chloramphenicol to the growth medium (Pearson’s r = 0.92, Spearman’s ρ = 1).
A comparison between predicted and measured growth rates is reported in Figure 3.10.
Changing flux rates in vitro or performing gene overexpression and partial knockdown
suggested by METRADE is less straightforward than performing gene knockout. How-
ever, the number of techniques to perform gene expression changes in bacteria is rapidly
increasing. The methods available to date have been recently reviewed by Yen et al. [176].
Our predictions on overexpression or partial gene knockdown can be implemented using
plasmids or through promoter engineering based on CRISPR-Cas, homologous recom-
bination or transposable elements, RNA programming devices [34], and engineering of
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Fig. 3.10 METRADE predictions and measured growth rates in a phenomics dataset.
(Left) METRADE predictions and measured growth rates for each subset of the dataset
used in this study. The subsets of conditions are denoted by (i) C-lim: titrated catabolic
flux through controlled inducible expression of the lacY gene; (ii) A-lim: titrated anabolic
flux through controlled expression of GOGAT; (iii) R-lim: inhibition of protein synthesis
with an antibiotic (chloramphenicol). (Right) Spearman’s ρ and Pearson’s r correlation
coefficients between METRADE and experiments. The p-value is reported in brackets.
While obtaining a good overall correlation (final row of the table) between experimentally-
measured growth rates and the biomass predicted by METRADE, we obtain the best results
in the conditions representing inhibited protein synthesis by supplying chloramphenicol to
the growth medium.
ligands to create sensors for regulation of gene expression [173]. Modulation of gene (or
protein) expression level can be achieved through engineering of ribosomal binding sites
[59, 129, 140] and promoters [3, 75, 170].
3.8.2 Case study II: Saccharomyces cerevisiae
As a first step, we test the multi-objective optimization in METRADE on a model of Sac-
charomyces cerevisiae S288c. We first optimize the ATP synthase flux rate and concurrently
maximize the biomass (Fig. 3.11). The model is constrained using experimentally-derived
upper bounds obtained by measuring uptake rates of 15 metabolites. Then, we perform a
variability analysis combined with the multi-objective optimization analysis. Specifically,
we focus on 149 fluxes provided by our collaborators and we perform a flux variability
analysis across the front by computing their flux rates for each solution on the Pareto front.
Across the Pareto front, we correctly predict changes in the acidity of the system. Indeed,
carbon dioxide (CO2) and carbonic acid (H2CO3) are kept in balance, and the flux variability
shows that their flux vary considerably along the front. These predictions were experimen-
tally confirmed by our collaborators. Another interesting result is predicted among the
amino-acids, where alanine showed a large variability across the front. Depending on the
region of the Pareto front, alanine is imported or released, therefore fulfilling both catabolic
and anabolic functions.
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Fig. 3.11 Multi-objective optimization of S. cerevisiae in the configuration that mini-
mizes (a) and minimizes (b) ATP while maximizing the growth, applying constraints
derived from experimental uptake rates of 15 metabolites. We show all the solutions
found by our algorithm: red points are non-dominated, black points are dominated. Each
point is a particular set of values for the flux rates in the model.
As a second step, we use METRADE to integrate transcriptomics into the yeast
metabolism. We consider a set of four experimental conditions (glucose- and ammonium-
limited cultures of two different deletion mutants, HO and QDR3). Both genes are not
included in the metabolic reconstruction, and their effect on the metabolism is still a matter
of debate. QDR3 is an efflux pump that acts as a hydrogen anti-porter. The analysis on the
QDR3 deletion would therefore give insights into the role played by QDR3 in the yeast
metabolism. We take the HO deletion as a control condition. As for microarray data, we
use the four microarray profiles corresponding to the four experimental conditions, and we
use METRADE to map them to the glucose-glycerol and ATPsynthase-biomass objective
spaces (Fig. 3.12), and finally to evaluate the resulting flux distributions. Remarkably, the
insights provided by METRADE were used by our collaborators to reduce the number of
orphan reactions, i.e., those that are not associated with any gene. While 33.9% of the
reactions in the complete network are orphan reactions, at least 21.6% of their fluxes show a
variation in one of the four conditions. We obtain the best result (27.1%) when minimizing
the glucose uptake and maximizing the glycerol production.
3.8.3 Case study III: Corynebacterium glutamicum
Corynebacterium glutamicum is a gram-positive bacterium used to industrially produce
amino acids such as L-glutamate and L-lysine. Amino acids are important industrial
products with a market of three million tons per year ranging from pharmaceutical products
to food and beverage [19]. Here, we consider a model of 518 reactions, 399 metabolites,
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Fig. 3.12 Mapping of four experimental conditions onto the objective space of glucose-
glycerol and ATPsynthase-biomass. Two different deletion mutants, HO and QDR3, were
grown in glucose- and ammonium-limited cultures. For each condition, we use METRADE
to constrain the model starting from the microarray data obtained in each condition, and
we use bilevel linear programming to optimize towards maximum glucose uptake and
maximum glycerol (a), minimum glucose uptake and maximum glycerol (b), maximum
ATP synthase and maximum biomass (c), minimum ATP synthase and maximum biomass
(d).
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Fig. 3.13 Multi-objective optimization of NADH:ubiquinone oxidoreductase, ethanol
production and biomass for the C. glutamicum. The Pareto front is also a powerful tool
for comparison of metabolic capability. In (a), the shape of the Pareto shows that, when the
bacterium is pushed towards increasing the flux of NADH dehydrogenase while ensuring
a high growth rate, only a few areas of the objective space are viable. Furthermore, the
relation between the two objectives is not linear, unlike when overproducing ethanol and
biomass (b).
and 468 genes [165]. To constrain the model, we use experimental flux measurements for
eleven exchange reactions: L-malate, fumarate, L-alanine, L-valine, L-Glutamate, acetate,
lactate, pyruvate, formate, glucose, CO2.
In a first setting, we optimize biomass as a first objective to maximize, NADH production
as a second objective to minimize, and the difference between our estimated succinate
production and the succinate production measured experimentally as a third objective to
minimize. The FBA controls NADH and biomass, while the PGA underlying METRADE
controls the biomass and the third objective. This approach is also called goal programming,
since it consists of defining an objective function as the absolute deviations from the targets
to the objectives [41]. We test this approach in three different experimental conditions. For
the first experimental condition, the best non-dominated point of METRADE consists of
1.6863 mmol h−1 gDW−1 of succinate against 1.5272 mmol h−1 gDW−1 measured in the
experiment. For the second experiment, 0.6595 mmol h−1 gDW−1 against 0.5880 mmol h−1
gDW−1. For the third experiment, we predict 0.4297 mmol h−1 gDW−1 of succinate flux,
against 0.4074 mmol h−1 gDW−1 found in the experiments. We note that in all the three
experiments our predictions are remarkably close to the experimentally-measured exchange
flux. With the same technique, we maximize the NADH:ubiquinone oxidoreductase, ethanol
and biomass (Fig. 3.13).
To further test METRADE, we compare the in silico results, obtained through multi-
objective optimization, with in vitro results, obtained for succinate production in specific
72
3.9 Discussion
-500 0 500 1000 1500 2000 2500 3000
0
0.005
0.01
0.015
0.02
0.025
0.03
Nadh2 [g h-1 l-1]
Su
cc
in
at
e 
[g 
h-1
 
l-1
]
RC0413_013_80_1
 
 
50
100
150
200
250
300
-1000 0 1000 2000 3000 4000 5000 6000
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
Nadh2 [g l-1 h-1 ]
Su
cc
in
at
e 
[g 
l-1  
h-
1  
]
RC0413_013_82_1
 
 
50
100
150
200
250
300
Fig. 3.14 Comparison between the points obtained by METRADE and the experi-
mental value (red line) of succinate in two different strains of Corynebacterium glu-
tamicum RC0413_013_80_1 and RC0413_013_82_1. The reaction named “Nadh2” is a
reversible reaction modeling the production/intake of NADH, with formula nad[c] + h[c]
<=> nadh[c]. Solutions found by METRADE are denoted by progressively warmer colors
according to the population in which they have been generated by the PGA.
strains (RC0413_013_80_1 and RC0413_013_82_1). In two different experiments, we
consider the strains able to maximize the production of succinate. As shown in Fig. 3.14, in
both cases there is a very good agreement between the experiments and our results, with
the Pareto front always automatically recovering points whose succinate is the succinate
measured experimentally, and in some cases also suggesting metabolic configurations that
would allow increased production of succinate with minimum NADH production.
3.9 Discussion
In this chapter we proposed METRADE, a multi-omic extension of FBA and GDMO able
to map environmental conditions to the variation of gene expression. We then investigated
the effect of different conditions on the phenotype (through the metabolic map). Our method
associates each gene expression profile with a flux distribution represented by a point in
a multidimensional objective space, which therefore becomes a condition phase-space.
Finally, we focused on the condition phase-space and we proposed a set of methods to
analyze the adaptability to experimental conditions. The principal component analysis
allowed exploring the directions with largest variance, indicating the relation between
the gene expression profiles and the variance in the two or more objectives chosen. The
hypervolume indicator used within METRADE focused on how the trade-off evolves in a
bidimensional objective space, highlighting periods of slow and fast evolution.
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The importance of mapping microarray profiles to a metabolic model before further
analyzing (e.g. clustering) their associated conditions, compared to the analysis performed
directly on gene expression data, is as follows. First, multi-omic models provide means for
clustering genes in their relative pathway; as a result, pathways can be effectively clustered
and ranked through an effect-based approach (i.e., looking at the distance between their
output outcomes in the phenotypic space) rather than looking merely at the expression
profile of their genes. Second, the model acts as a ranking and noise-reduction tool, since
the effect of low-importance genes is filtered out even if their expression is highly variable
across conditions; without the multi-omic model, these genes would be incorrectly regarded
as key genes to differentiate conditions. Third, performing inference directly on gene
expression values may lead to incorrect prediction of the centrality of a gene whose level
seems to be highly correlated with many other genes, but with only a marginal role in the
metabolism (e.g., no impact on the biomass and on key metabolites).
The use of gene expression and codon usage as layers of the multi-omic model allows
simulating growth on different media or environmental conditions. On the integration of
gene expression data in the metabolic model, we note that related methods (e.g., GIMME
[20] and iMAT [184]) need binarization or discretization of expression values. Conversely,
we do not need to set any arbitrary threshold, and therefore we do not need to assume that
only some reactions are present in the model. A further limitation of these methods is that
considering only one objective or a linear combination of objectives (usually encoded in
the biomass reaction) is not sufficient to find all the possible metabolic states in which
the maximization of a given product is performed with the maximization of the biomass
on various substrates. In this regard, the use of a multi-objective algorithm is key to
obtain all the possible trade-off relationships among objectives, thus overcoming one of
the major limitations of bilevel FBA, namely the estimation of only one point solution in
the bidimensional objective space. With our multi-objective approach, we provide a wider
range of solutions ensuring optimal values for all the objectives.
METRADE is freely available as an extension of the COBRA 2.0 toolbox, and can be
easily integrated with the methods we used in Chapter 2 to investigate the Pareto front: (i)
the sensitivity analysis, to quantify the importance of parameters and variables in the model;
(ii) the robustness analysis, to evaluate how a proposed strain is robust to local and global
perturbations [44]; (iii) the identifiability analysis, to find functional relations between
variables [8]; and (iv) the ε-dominance analysis, to consider all the feasible solutions that
are dominated with a tolerance ε with respect to Pareto solutions.
Finally, METRADE can be used to detect “internal” communities of conditions, where
the closeness is measured on the response of the multi-omic model; it is therefore possible to
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create a correspondence with the “external” communities of conditions, where the closeness
is usually knowledge-based or measured directly on the features of the environmental
conditions. Due to the continuous nature of METRADE, we expect it will be used for
calibration of genome-scale models, and in combination with dynamical aspects of FBA
with the aim of detecting communities of conditions over time (e.g., reiterated shifts to
completely different external conditions or growth environments). Coupled with advanced
prediction techniques, for instance Bayesian “missing values” methods, METRADE can
infer the response to conditions for which gene expression data are missing or incomplete.
Therefore, it could represent an innovative tool for biologists for investigating important
aspects of bacterial evolution, such as: (i) how genomic, metabolic, transcriptomic variations
shape the complex adaptation landscape of bacteria; (ii) the ecological (condition-based)
degree of coherency for bacterial genospecies; (iii) the relationship between speciation,
ecotypes and ecological (condition-based) diversity; (iv) the adaptive response to different
dosages of antibiotics and bacteriostatic chemicals.
3.10 Related work and final remarks
The work presented in this chapter has been accepted for publication in Nature Scientific
Reports [11]. A spectral method for community detection, the pseudospectrum and its
bagplot were used to further analyze the experimental conditions and to shed light on the
structure of a distance matrix built on the space of environmental conditions. The algorithm
for community detection of conditions aims at clustering conditions according to their
similarity in the objective space. The pseudospectrum is instead aimed at gaining insights
into the distribution of the position of each condition in the objective space in presence of
uncertainty due to external perturbations.
Part of the method for integration of omic data in the metabolic model, coupled with a
Bayesian method for inferring pathway cross-correlations and pathway activation profiles,
has been published in ACS Synthetic Biology [12]. I performed all the analyses described
in these papers and included in the dissertation. The Bayesian analysis, not included in the
dissertation, was contributed by N. Pratanwanich.
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Chapter 4
Metabolic models as biological
computers
Here we introduce a relation between computation and metabolism explained through a
formalism that associates the structure of any bacterium with a von Neumann architecture.
First, we discuss this mapping by viewing the metabolism as a Minsky register machine
with universal computing capability. Then, we discuss the effect that various events (e.g.,
motility, communication, gene duplication) may have on the computation performed by a
bacterium. Finally, we highlight the changes occurring in the computation capability as a
consequence of a duplication event followed by a mutation.
The aim of this chapter is to propose a way to interpret the metabolism as a Turing
machine and, in general, the full cell as a von Neumann architecture. This also leads to
estimate the “computational power” of a set of reactions, which can be defined as the
number of final states that they can reach, and depends on the reactions themselves and on
various constraints that must hold. Metabolic engineering (for example strategies proposed
by GDMO and METRADE in the previous chapters) is a way to program these machines
and drive them towards a desired output.
4.1 Can biological processes compute?
If Turing were a first-year graduate student interested in computers, he would probably
migrate into the field of computational biology. In 1952, he outlined computational pro-
cesses in morphogenesis [162], thus thinking of the biological development of an organism
as a consequence of the computation that it can perform. Following Turing’s idea on mor-
phogenesis, many biological processes have been recently analyzed from a computational
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standpoint. For instance, in 1995, Bray argued that a single protein is a computational or
information-carrying element, being able to convert input signals into an output signal [26].
Turing’s idea is that the computation carried out by an organism allows it to move from one
development pattern into another. For instance, multi-cellular organisms can be thought of
as the product of the computation started from a single cell, which is capable of running a
program like that of a computer [28]. This leads us to speculate that the instructions of the
code executed in an organism are responsible for driving its behavior and evolution.
Evolution had already been associated with computation many years before, by von
Neumann and Burks [168], who constructed a self-replicating cellular automaton with
the aim of developing synthetic models of a living organism. Recently, the theory of self-
reproducing machines has been thoroughly analyzed by means of text register machines
[116] or self-modifying register machines [109]. Several programming languages have been
developed and analyzed for modeling biological computational processes. A computational
process has been discovered also in ciliates during the unscrambling of genes [97], showing
many points in common with the Adleman’s algorithm [1], where a DNA computer is
able to solve the instances of the NP-complete Hamiltonian path problem. Therefore, a
computation having a micronuclear sequence as input can yield a functional macronuclear
gene, meaning that a guided genome recombination system can simulate a Turing machine
[4]. In a molecular machine, there is increasing evidence that the DNA is the part of the
cell simulating a memory storage [150].
Here we propose a relation between computation and metabolism explained through
an effective formalism. In particular, we associate the structure of a bacterium with a von
Neumann architecture, showing that the components of a bacterium can be mapped to a
processing unit, a control unit, a memory storing the “program” of the bacterium, and an
input-output section. The genome sequence is thought of as an executable code specified by
a set of commands in a sort of ad-hoc low-level programming language. In this way, the
bacterium becomes a molecular machine with computation capability. Furthermore, the
set of all its chemical reactions represents a processing unit, and we show that the entire
metabolic network works as a Turing Machine [5].
Using the metabolism to actually perform computation means that one needs to be able
to explicitly track the exact number of each molecular species (as in the Gillespie algorithm
[68]). This is currently possible for extremely small systems with a limited number of
reactions. In vitro, “single molecule tracking”, i.e. a set of methods for tracking single
molecules in living cells, is still in its infancy [95].
The methodology proposed in this chapter aims at addressing the challenge pointed out
by Weiss [172], i.e., to ensure robust computation in cells, with reliable and reproducible
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results. This would lead to effectively modify and harness biological computers for our
purposes. Running a program in a molecular machine can represent an effective intervention
in a cell, driving it towards the modification of its behavior according to the available
inputs and the desired outputs. Although modeling the whole life of an organism as a
Turing machine would certainly be computationally unfeasible, our approach is aimed
at explaining the single operation executed by a bacterium in light of a computational
instruction. Interestingly, our approach can be readily used to evaluate the computational
effort for a specific task, or the computational capability of the whole organism under
investigation.
4.2 Abstract models of computation
4.2.1 Turing machine
A Turing machine (TM) is a mathematical model describing a read/write head manipulating
symbols on a tape. This model, proposed by Alan Turing in 1936 [163], is widely recognized
as the first model of a “general purpose” computer. Formally, a TM is defined as a 7-uple
T = (Q,Σ,Γ,δ ,q0,qa,qr), (4.1)
where: Q is a finite set of states of the machine; Σ is a finite input alphabet and does not
contain the blank symbol; Γ ⊃ Σ is a finite tape alphabet and contains the blank symbol.
The initial input received by T is a set of symbols in Σ (and therefore also in Γ) written in
the first n locations of the tape. Since Σ does not contain the blank symbol, the first blank
symbol on the tape indicates the end of the input. The head starts at the leftmost location of
the tape. The function
δ : Q×Γ−→ Q×Γ×{L,R} (4.2)
is the transition function controlling the steps of the machine: when T is in a given state
q ∈ Q and its head is in a location containing a ∈ Γ, if δ (q,a) = (r,b,R), the machine
replaces a with b, leaves state q, enters state r, and moves right (or moves left if δ (q,a) =
(r,b,L)). Note that if the machine is in the leftmost (or rightmost) position of the tape, and
δ indicates to move left (or right, respectively), the machine stays in place. The states
q0,qa,qr ∈ Q, with qa ̸= qr, are three distinguished states indicating respectively the start
state, the accept state, and the reject state. The machine halts when it reaches qa or qr.
Intuitively, a TM is a finite state machine working on a tape. The tape is divided into
discrete locations, where each location can contain one symbol from a finite alphabet.
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Given its current state and the symbol found in the current location, the TM writes a new
symbol in that location and moves in a new location. The TM is now in a new state. Note
that the new location can be the same as the old location, i.e., the machine stays in place;
analogously, the new symbol written in a location can be the same symbol that was already
in that location. The machine has a specified initial state, and may also decide to halt. Given
the state of the machine and the symbol that the machine is currently reading, the operations
performed by the machine are described in a program specifying the actions to perform.
Therefore, a TM provides a formal definition of computability in the discrete domain. At a
given time, the configuration of the TM is given by the state of the tape, the state of the
head and its position on the tape.
4.2.2 Minsky register machine
A counter machine, also called Minsky register machine (RM), is also an abstract model of
computation. The formal definition of Minsky machine
M = (D,H, i0, i1,ϕ) (4.3)
includes a finite set D of states, a finite set H = {Hr}r of registers, and a multivalued
mapping that governs the transition from one state to another:
ϕ : D\{i0} −→ {(Hr, i),(Hr, j,k) | Hr ∈ H, i, j,k ∈ D}. (4.4)
The initial and the halting states are two distinguished elements i1, i0 ∈D. The RM executes
two basic increment/decrement instructions: (i) inc(i,r, j) to increment register r by 1
and move from state i to state j according to ϕ(i) = j; (ii) dec(i,r, j,k), with Hr > 0, to
decrement register r by 1 and move from state i to state j (ϕ(i) = j); if Hr = 0, the machine
moves from state i to state k (ϕ(i) = k). The RM also has a halt instruction that halts its
operation, setting the state i0.
A two-register Minsky RM has been proven to be equivalent to a TM [113]. Intuitively, a
RM is a multi-tape TM with the tapes restricted to act like simple registers (i.e., “counters”).
A register is represented by a left-handed tape that can hold only positive integers by writing
stacks of marks on the tape; a blank tape represents the count ‘0’. The RM registers are
monosymbolic and not bounded, i.e., they are stacks containing the same symbol repeated.
Each register can be either incremented or decremented (if it is nonzero, otherwise the
instruction is ignored and the machine proceeds to the next instruction).
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Fig. 4.1 Comparison among biological systems (a), von Neumann architecture (b), and
bacteria (c). The string y in (c) is a program stored in the RAM and written in an ad-hoc
low level programming language. The map gΦ represents the control unit: it interprets
the binary string y and turns gene sets off. The processing unit is the metabolism of the
bacterium, composed of all the chemical reactions that take place in it. The goal is to
produce desired metabolites as output of the molecular machine.
4.3 Bacteria as von Neumann architectures
It is well known that a von Neumann architecture is composed of a processing unit, a
control unit, a memory to store both data and instructions, and input-output mechanisms.
Similarly, the bacterium takes as input the chemicals (substrates) necessary for its growth
and duplication, and uses its biochemical network (coded by the genes of its genome)
to produce metabolites as output [5]. Inspired by Brent and Bruck [27], who studied
similarities and differences between biological systems and von Neumann computers, in
Fig. 4.1 we propose a mapping between the von Neumann architecture and bacteria. This
mapping leads to thinking of the metabolism as a Turing machine, and of the knockout
string y obtained by GDMO as a “program” that drives the machine.
Let us consider the multiset Y of the bits of y. A partition Π of the multiset Y =
{y1,y2, ...,yL} is a collection {b1,b2, ...,bp} of submultisets of Y that are nonempty, disjoint,
and whose union equals Y . The elements {bs}s=1,...,p of a partition are called blocks. We
denote by P(Y ; p) the set of all partitions of Y with p blocks. P(Y ; p) has a cardinality equal
to the Stirling number, namely |P(Y ; p)|= SL,p [155]. In order to formalize the behavior of
the control unit, let us define the function:
gΦ : {0,1}L −→
⋃
y∈{0,1}L
P(Y ; p) (4.5)
y¯ ∈ {0,1}L 7−→Π ∈ P(Y¯ ; p), (4.6)
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Fig. 4.2 The multiset Y associated with y is partitioned by Π in p blocks. The elements
of Π are submultisets of Y , since y is a string of bits, thus 0 and 1 may occur more
than once in the same subset. In this example, Π = {{y4} ,{y1,y6,y2} , . . . ,{y5, ...,yL}},
Φ= {{4} ,{1,6,2} , . . . ,{5, ...,L}}.
where the partition Π is uniquely determined by the pathway-based subdivision of the
chemical reaction network that we find in metabolic models. This subdivision, in turn,
can be formalized as a p-blocks partition Φ of the set of the bit indices in the string y. In
particular, if we denote by [L] the set of the first L natural numbers, we have Φ ∈ P([L] ; p).
According to the partition Φ, the control function gΦ partitions the multiset Y associated
with the string y (see Fig. 4.2).
The function gΦ plays the role of the control unit, since it interprets the binary string y
and turns gene sets on and off, according to the pathway-based partitioning of the reactions
occurring in the bacterium. Each element of the partition Π is the submultiset bs of all the
gene sets that play a role in the reactions belonging to the sth pathway. In other words,
gΦ turns syntax into biological semantics. The processing unit of the bacterium could
be modeled as the collection of all its chemical reactions. In this regard, a TM can be
associated with the chemical reaction network of a bacterium [152]. The useful metaphor
to frame a biological systems as a von Neumann computer hinges on the representation of
the metabolism as a TM [5], as summarized in Table 4.1.
Biological organism von Neumann Bacterium
input metabolites input input metabolites
output metabolites output output metabolites
control control pathway handling gΦ
genome memory knockout string
metabolism processor TM
Table 4.1 Bacteria as von Neumann architectures. Dictionary translating the general
biological organism (left) into the computational concept of the von Neumann architecture
(center) and the equivalent in a bacterium, according to our framework (right).
The sections of the von Neumann architecture mapped to an evolving bacterium are
shown in Fig. 4.3. The substrates required for the growth of the bacterium are represented
by the input module of the architecture. The memory module contains the knockout
string y obtained by GDMO, which plays the role of the “program” responsible for protein
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production in the cell. The chemical reaction network reads and executes the program
y, converting input metabolites into output products [5]. The control unit g activates or
deactivates gene sets translating the binary string y (syntax) into knockout instructions
performed in the metabolic network (semantics). The network of the bacterial metabolism
and the availability of nutrients drive this process. The evolution is represented as an
increased capability of biological computation (e.g. ability of producing new chemicals)
due to an enlarged genome. We will analyze this scenario in Section 4.5.
y ∈ {0, 1}L
Chemical
reactions
TM
Input Output
metabolites metabolites
g Clock
TM
y ∈ {0, 1}L
Input
y ∈ {0, 1}L+k
Evolution
Clockg
Chemical
reactions
metabolites
Output
metabolites
Fig. 4.3 The sections of a von Neumann computer can be found in evolving bacteria.
The string y is a knockout genetic strategy, i.e., the program stored in the RAM and
responsible for protein synthesis. The function g represents the control unit of the computer,
interprets the program y and handles gene sets so as to produce desired amount of proteins.
The metabolism is the processing unit, composed of all the chemical reactions of the
bacterium and mapped through a Minsky machine. The clock module communicates
with the register logic module in a way that ensures a low probability of error per step.
Metabolites of interest are produced as output of the molecular machine. The evolution and
growth of a bacterium depend on duplication and mutation events occurring in the program
(genome) and in its length.
4.4 Metabolic networks as Turing machines
Interestingly, the metabolism of a bacterium can be regarded as the processing unit of
the von Neumann architecture, as it has been proved to be able to perform computation
[152]. More specifically the metabolism can be mapped to a Minsky register machine (RM),
where each register represents the molecular count of a single chemical species, and is a
left-handed tape that stores non-negative integers by writing stacks of marks on the tape. A
RM is equivalent to a multi-tape TM.
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4.4.1 A map between a chemical reaction network and a register ma-
chine
The chemical reaction network of a bacterium can be simulated with a RM, by defining
sets for state species and register species [152]. In the set of register species {Hr}, each Hr
counts how many molecules of species r are present, and corresponds to the rth register
of the RM. In the set of state species {Di}, each Di corresponds to the ith state of the
RM. More specifically, Di is an auxiliary species representing only one of the states of the
metabolic network, and does not correspond to any existing chemical species. For every
state of the RM, the molecular count of the state species associated with that state will be 1,
and the count of all the other state species will be 0. The instruction inc(i,r, j) is mapped
to the chemical reaction Di → D j +Hr, and the instruction dec(i,r, j,k) is mapped to the
reaction Di+Hr → D j if Hr > 0, or to Di → Dk if Hr = 0. Note that the reaction Di → Dk
can occur only if Hr is over, since the rth register cannot be decreased and the reaction
Di+Hr → D j is not feasible. In this way, the bacterium executes a “test for zero”. Finally,
the halt instruction is equivalent to the cell death, when no further chemical reactions take
place [64].
As regards the computation rate in a cell, given that the total number of proteins per cell
is approximately 5 ·107 (e.g., for the budding yeast [67]), and on average enzymes carry out
10 s−1 reactions (far lower than the common examples found in textbooks [17]), we have
5 ·108 instructions performed every second by the molecular machine. Each instruction
consists of multiple decrement and increment instructions for the registers involved in the
reaction, e.g., executed through a multi-core architecture. This leads us to estimate a 5 ·108
Hz (or 0.5 GHz) computation rate in each yeast cell. Reversible reaction can be translated
into two different instructions, therefore increasing the computational capability of the
molecular machine.
A program executed in an organism could be able to implement the genetic strategy
proposed by GDMO as the program y. Furthermore, since the simulated TM is an universal
machine, our mapping would allow a bacterium to theoretically perform any computation
performed by a computer, using its species and reactions characterized by their flux. How-
ever, the desired output can only be guaranteed with high probability, due to the inherent
stochasticity and constraints of chemical reaction networks.
4.4.2 A clock module to enforce the order of reactions
In order to enforce the order of reactions that take place in the register machine, a clock
module can be used to communicate with the register logic module [43]. The clock sends
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a signal in the form of an auxiliary species C to the register module, and when a step is
performed in that module, C is converted into another auxiliary species T , which is sent
back to the clock. After a given delay, the clock sends C again to perform another step. Like
the state species {Di}i, C and T are auxiliary species with no actual chemical counterpart.
The delay can be controlled in a way that ensures a low probability of error per step.
More specifically, an error of the register machine consists of disabling a decrement reaction
Di +Hr → D j involving a species Hr that is still available but with only one molecule
left (|Hr| = 1). This error can happen if a new clock signal C is sent before the reaction
Di+Hr → D j takes place during a decrement step, therefore Di has not been captured and
the reaction Di +C → D0 +T could take place first; if this happens, the presence of D0
would incorrectly indicate that the register Hr is empty.
The case where |Hr| = 1 is indeed the scenario most prone to error because of the
low probability that the last decrement step Di+Hr → D j takes place quickly, due to the
presence of only one molecule of Hr in the chemical solution. Since the decrement reaction
has a rate independent of the clock (e.g., related to the FBA flux rate at steady state, or to
the number of molecules of reactants), the role of the clock here must be to delay the release
of C. This imposed delay maximizes the probability that the correct decrement reaction
Di +Hr → D j occurs first, and therefore minimizes the probability of error per step. If
this happens correctly, Di is consumed and consequently Di+C → D0+T is not allowed
to take place, while the reaction D j +C → D0+T will take place if another decrement is
requested for Hr.
4.5 Gene duplication and transfer in communicating molec-
ular machines
Bacterial conjugation is a genetic transfer that involves cell-to-cell interaction between
donor and recipient cells. The importance of horizontal/lateral gene transfer (LGT) in
shaping the genomes of prokaryotic organisms has been recognized in recent years as a
result of analyses carried out on an increasing number of available genome sequences. LGT
is largely due to the transfer and recombination activities of mobile genetic elements. Let us
consider the case that genes on some chromosome can circulate and be transmitted among
interacting bacteria. (This can occur, for instance, when a bacterium acquires antibiotic
resistance, i.e., tries to become immune to some antibiotic drug.) Here we try to address
the question whether the computation occurring in each bacterium is affected, and to what
extent. An exchange of genes modifies the program running in each molecular machine, and
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consequently affects the protein production in all the bacteria involved, except the donors if
the gene is copied. This leads to a change in the evolution of the bacterial network [21].
In a communication session between two bacteria, a bacterium duplicates one piece of its
genome and sends it to another bacterium, which engulfs it and increases its computational
capability, consequently decreasing the speed of cell division. Therefore, the computation
in the second bacterium changes accordingly, whereas the operations taking place in the
first bacterium are not affected. Indeed, in the mapping between a bacterium and a von
Neumann architecture, the metabolites are mapped to the variables of the code. Since the
engulfed genes were needed by the second bacterium, they are likely to be responsible for
reactions involved in the production or consumption of its key metabolites (i.e., increment
or decrement of internal variables). Hence, they are likely to have a significant effect on
the next instructions performed by the TM, as well as on the whole metabolic network.
Conversely, since the first bacterium performs a duplication that is not needed by itself, the
operations associated with the gene duplication are expected to be carried out by dedicated
tapes of the TM.
Gene duplication is another source of new cellular functions, giving improved com-
putational capability to the organism. In an evolutionary process, given a sequence of
genes, a subsequence of genes (e.g., an operon), or even a single gene are often duplicated
and inserted somewhere else in the sequence [38]. This process is referred to as gene
amplification or gene duplication. Given an organism with L gene sets, and assuming each
gene set is composed of a single gene, without loss of generality, let us denote by y the
array representing the sequence of its genes. Let us assume that the duplication of the last k
genes is performed:
y = (y1, ...,yL) −→ y = (y1, ...,yL,yL+1, ...,yL+k). (4.7)
Initially, the condition of duplication holds, i.e., the last gene was duplicated k times,
namely yl = yl−k, ∀l = L+1, ...,L+ k. In general, the duplication is a stochastic process
and the condition of duplication is not always true. After the duplication, the string becomes
y= (y1, ...,yL′), where L′ = L+k, due to the fact that mutations affect both new and existing
genes. Each gene yl codes for a reaction, say Di →D j+Hr, and therefore for the instruction
inc(i,r, j) in the RM. After the duplication, both yl and yl+k will be responsible for the
same reaction Di → D j +Hr. Conversely, after the mutation, the mutated gene y′l+k will
be responsible for another reaction, say Di′ → D j′ +Hr′ . If the reaction is not already
controlled by other genes, a new reaction inc(i′,r′, j′) is now operating in the RM, namely
there has been an increase of complexity of the metabolic machine.
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Each gene engulfment, or gene duplication followed by a mutation, can change the
computational capability of the organism, i.e., the performance of the metabolic machine
associated with it. This increases the number of feasible solutions in the multi-objective
optimization, and therefore the area under the Pareto front. In cases like biofilms or bacterial
communities, the goal may be global and shared among bacteria. As shown in Fig. 4.4, a
bacterium can engulf a piece of genome duplicated and sent by another bacterium. This
process increases the genome length, allowing more knockout strategies, a different shape
of the Pareto front, and causing not merely an increased complexity of the control function,
but also a larger capability of intake and output production.
A mutation can be thought of as a stochastic process proposing a new instruction for
the machine, while natural selection, acting as a biological ratchet gear, can keep it or
discard it. Consequently, the combination of stochastic processes and natural selection
shapes the computational complexity of an evolving organism. In particular, the genome
amplification increases the number of available chemical reactions, creating new increment
and decrement instruction in the RM associated with the metabolism, thus increasing the
computational power of the whole metabolic machine. However, since a longer genome
needs to be duplicated during cell division, the growth rate is likely to be affected. Further
discussion on the topic can be found in [6].
4.6 Related work and final remarks
The main theoretical results presented in this chapter have been published in Theoretical
Computer Science [9], and in the Proceedings of the Turing Centenary Conference [5].
The problem of communicating bacteria is further discussed in a paper published in Nano
Communication Networks [6]. I performed all the analyses related to the mapping described
in this chapter.
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Fig. 4.4 Interacting bacteria can be thought of as communicating von Neumann archi-
tectures (left, center). Due to the communication between the two bacteria (left, center),
the second bacterium engulfs a piece of genome (right) duplicated by the first bacterium.
In a multi-objective optimization analysis, this results in an increment of the area under
the Pareto front. In other words, the evolution and the growth of a bacterium can be the
result of duplication and mutation events in the genome of another bacterium. For instance,
the bacterium may engulf k genes and increase the size of its chemical reaction network,
therefore increasing also the ability to import and export metabolites.
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Chapter 5
Conclusions and future directions
The advent of high throughput data in biology requires computational techniques for data
mining, analysis and extraction of knowledge. Biologically-inspired computation has been
used to infer mathematical models, parameter values, or to capture states and transitions at
the molecular level [61]. As a result, mathematics, computer science and biology are now
tightly linked.
The tools provided in this dissertation represent a starting point for modeling adaptive
dynamics in genome-scale models, and for elucidating genotype-phenotype relationships
in bacterial cells. In Chapter 2, we developed an optimization framework for genome-
scale models, in which we proposed GDMO, a method for multi-objective metabolic
engineering based on FBA. We adopt the GDMO algorithm to find genetic manipulations
in order to maximize multiple biological requirements, i.e., growth rate and a product of
biotechnological interest. In the same optimization framework, we propose a solution for
the problem of making the sensitivity analysis pathway-dedicated: we develop a pathway-
based sensitivity analysis (PoSA) to investigate the functional components of the model
and compute their sensitivity. The robustness analysis supports GDMO and PoSA in that it
indicates the components of the model that are likely to “fail”.
The Pareto front has a close link with biotechnological productivity. For the biosynthesis,
Pareto optimality is important to obtain not only a wide range of Pareto optimal solutions,
but also the best trade-off design, providing a visualization of the optimization process and
significant details for metabolic design automation. The size of non-dominated solutions,
the first derivative and the area under the Pareto front could play a key role for the best
design within the same organism or between different organisms. For instance, a reduced
size of the Pareto front could suggest the incompleteness of the model in terms of number
of reactions modeled; in this case, Pareto optimality could be thought of as a parameter
describing the improvement of a model for a bacterium with respect to a previous model
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for the same bacterium. The idea of multi-objective optimality can also be harnessed in a
network of organisms. Indeed, two communicating organisms can define their behavior by
making a trade-off decision using a shared Pareto front in which each organism is associated
with one or more axes of the objective space.
Exploratory analysis and comparative metabolic models also suggest that the area under
the Pareto front provides an estimate of the number of intermediate solutions which may
be exploited for biotechnological purposes (optimization of an additional objective) or to
build synthetic pathways (synthetic biology). Given two bacteria or two conditions for the
same bacterium, a larger area under the Pareto front probably represents better conditions
for adding or optimizing pathways leading to new products. The robustness analysis allows
for the discrimination of the optimal strains generated as a result of the multi-objective
optimization: the higher the robustness indices, the larger the probability that the bacterium,
reproduced in laboratory, maintains the desired performance. Overall, local robustness
analysis enables us to reach a better understanding of the fragility of the metabolic network.
Bacterial adaptability to new environmental conditions involves shifts in the gene
expression and in the biochemical network, also in places that are not always related directly
with the adaptation. For instance, an increase in the amount of a given nutrient supplied to
the bacterium will increase the request for the enzymes – and consequently for production
of reactants – able to produce that nutrient [134]. Although increasing research efforts have
been allocated for attempts at understanding the relation between gene expression changes
and phenotype in bacteria, little is known about the contribution of the different omics and
different objectives to the phenotypic adaptability and evolution.
To account for bacterial adaptability and omic layers of information, in Chapter 3
we derived METRADE, a novel multi-omic FBA method that implements and combines
multiple target optimization with gene expression and codon usage as additional layers for
the most complete metabolic data available for Escherichia coli. Given an E. coli strain with
a specific gene expression configuration, METRADE is able to determine the best codon
usage for each gene so as to maximize or minimize desired objective functions. We show
how the integration of multiple omics can be used to compare different bacterial strains
and evaluate the optimal behavior of a bacterium under various conditions. Specifically,
the environmental conditions are mapped to genotypic data (gene expression profiles), and
finally to phenotypic data (predictions of two or more optimized variables). This enables
the use of the Pareto front to predict where the metabolism operates in the objective space
[145], to investigate scenarios of adaptability over time, and, coupled with its hypervolume,
as an indicator of the evolution of a strain.
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GDMO and METRADE scale effectively as the size of the metabolic system and the
number of genetic manipulations increase. Moreover, our results show that the multi-
objective approach is suitable for discovering genetic design strategies. Our software tools
allow for the analysis of an organism in a dynamic multi-omic fashion (genomics, tran-
scriptomics, proteomics) [50, 83], e.g., by evaluating temporal changes in gene expression,
codon usage and flux rates at various cellular levels. This allows for these layers to be
interpreted as a whole, and to evaluate connections and interactions among them. We
provide our algorithms as a MATLAB toolbox.
As described above, the growing availability of multi-omic data, in combination with
methods like METRADE and frequently updated genome-scale models, provides a highly
comprehensive view of cellular processes at the levels of mRNA, proteins, metabolites, and
reaction fluxes. However, to date, interactions at the pathway level cannot be measured
directly, and methodologies for prediction of pathway cross-correlations from FBA and
reaction fluxes are still missing. Therefore, in joint work with N. Pratanwanich, using
METRADE and a genome-scale model of E. coli we developed a hybrid method combining
multi-omics FBA and Bayesian inference [12]. The aim was to investigate the cellular
activities of a bacterium from the transcriptomic, fluxomic and pathway standpoints under
different environmental conditions. We determined the degree of pathway responsiveness
and detected pathway cross-correlations (crosstalks) starting from gene expression profiles.
A dynamical analysis allowed us to predict profiles of pathway activation over time in
changing environmental conditions.
In this research work, we were particularly interested in investigating pathway crosstalks
in different glucose and oxygen conditions. In Fig. 5.1, we take into account the maxi-
mization of biomass and acetate in E. coli, and we compare pathway responsiveness to
three different conditions, showing the correlations between pathways. In Table 5.1 we
show the responsiveness of the three most responsive pathways in different conditions,
with changing glucose and oxygen uptake. The pathway PID:5 (nucleotide salvage) is the
most responsive in those conditions in which only one pathway is responsive. Furthermore,
when two pathways are highly responsive, these are PID:17 (valine, leucine, and isoleucine
metabolism) and PID:25 (alanine and aspartate metabolism). For those conditions that have
three responsive pathways, these are PID:5, PID:17, PID:25. This shows strong correlation
among these three pathways when the model is aimed at the maximization of acetate and
biomass.
While metabolic models provide useful insights into complex cellular processes, the
development of a whole-cell multiscale model is still considered to be the Holy Grail in
computational systems biology [160]. The work from Karr et al. [85] provides a first draft of
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Fig. 5.1 Bayesian pathway analysis in E. coli. Comparison of pathway responsiveness to
different conditions (top). For example, among the 37 pathways in the E. coli model, two
pathways (PID:17 and 25) have high responsiveness to condition 1 and 466, while only one
pathway (PID:5) highly responds to condition 250. Crosstalks between pathways can be
viewed as a correlation matrix (bottom). The 466 experimental conditions we used for this
analysis are publicly available in [58].
a whole-cell simulation for a small bacterium, but we are still far from reaching whole-cell
modeling for larger cells. Starting from the E. coli FBA metabolic reconstruction, we are
also interested in a coarse-grained approach to whole cell modelling. We are currently
focusing on the regulation of the energy metabolism by the master regulator FIS. The
core of our approach is represented by a dynamical hybrid model of FIS regulation: the
expression of the FIS protein (modelled as an ordinary differential equation) regulates the
twisting of the DNA (modelled as a discrete birth/death process representing the number
of twists in the DNA), which regulates access of genetic material to the transcriptional
machinery, and in turn controls the production of FIS. FIS is linked to the metabolism by
modelling the way in which it regulates 104 genes in the FBA model. Another parameter
that affects regulation is DNA coiling. Our preliminary results (Fig. 5.2) show how FIS and
DNA coiling are able to regulate the growth rate and the synthetic yield of E. coli.
Further extensions of FBA in the field of whole-cell modeling may focus on combining
estimated mutation rates, transcriptomic program complexity and variance, and selection
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High glucose Low glucose
PID Pathway Aerobic Anaerobic Aerobic Anaerobic
5 Nucleotide salvage 0.0865 0.0965 0.1366 0.1714
17 Valine, leucine, and isoleucine metabolism 0.2219 0.2147 0.1974 0.1590
25 Alanine and aspartate metabolism 0.1544 0.1487 0.1285 0.1076
Table 5.1 Average responsiveness of the most responsive pathways across aerobic and
anaerobic conditions of high and low glucose in E. coli. The high/low glucose thresh-
old is 10 mmolh−1gDW−1. PID:5 is important in anaerobic conditions on low glucose,
while PID:17 and PID:25 both exhibit a key role in aerobic conditions on high glucose,
highlighting a pathway crosstalk between them.
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Fig. 5.2 Variation of biomass and acetate against FIS concentration (fold-change with
respect to the initial concentration). The parameter nti is associated with DNA twists,
varies in {1, 10, 20}, and models the level of bending and coiling of the DNA structure,
which affects rate of translation of genes into proteins. For every value of nti, the biomass
increases as the FIS value rises, reaching the maximum value for nti = 10. The acetate
reaches the highest values for nti = 1.
coefficients, with the aim of providing an upper-bound estimation of the number of traits
that can become and remain adapted by direct natural selection, i.e., the “many-traits”
and “few-traits” phenotype-fitness maps [56]. The framework can also be extended to
other bacteria that show variation of codon usage [94], and to other environments. A very
interesting medical application would be to simulate in silico the tumor conditions analyzed
for the Clostridium bacteria [135].
With our framework, we also plan to study endosymbiosis and host-pathogen interac-
tions, therefore designing, analyzing and optimizing the metabolism of systems composed
of different interacting species living and interacting in the same context, as introduced by
Cottret et al. [45]. This type of analysis could highlight the complementarity of separate
metabolic networks. For instance, mitochondria and chloroplasts are different organelles,
(usually) both found in plants, and are part of the same functional pipeline: starting from
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CO2, the photosynthesis in the chloroplast creates glucose that enters the mitochondria
to create ATP. We plan to study and optimize interacting metabolic networks using the
DyMMM framework [182].
Genome-scale modeling and the methods proposed in this dissertation can be also ap-
plied to human cells. Recently, a community-driven reconstruction of the human metabolism
has been developed, which incorporates also information on enzymes and genome, includ-
ing the relationships between genes, proteins and reactions [159]. This model, named
Recon2, contains all the chemical reactions known to take place in the human cell, and
has been recently tailored to different tissues, therefore obtaining unprecedented tools for
analysis of cell-specific behavior. We will add additional omic layers to the models, for
more accurate predictions of the phenotype (Fig. 5.3). Furthermore, using multi-tissue
phenotype data sets, we would like to better calibrate Recon2 and improve its prediction
accuracy. We are also interested in adapting these techniques for recently developed cancer
models [118], and in cross-comparing their behavior with that of normal cells across a wide
set of environmental conditions.
Fig. 5.3 Multi-objective minimization of isocitrate dehydrogenase (shown to be a
metabolic oncogenic factor) and maximization of growth rate in a human cell. This
technique is useful to detect the regions where the cell operates in the objective space. Each
point in the phenotypic objective space represents a solution, and corresponds to a specific
gene expression profile. Solutions are denoted by progressively warmer colors according to
the time step when they have been generated in the optimization process.
Both GDMO and METRADE could be further extended and tuned to specific cases, in
presence of additional information on enzymes. A further extension of the framework could
be the task of inferring the topology of the network of conditions using a multidimensional
scaling approach [178]. Such computational analysis can have a great impact especially for
the large fraction of microorganisms that have been already identified but never cultured so
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far. For instance, a step forward would be to infer pathways to combat condition-dependent
infections caused by bacteria involved in both plant and animal infections.
As regards human infections caused by bacteria, using multi-objective optimization
and model-predictive control applied to multi-scale models (e.g., a host-pathogen model
of E. coli and human metabolism Recon2), we aim to model the problem of antimicrobial
resistance, recently reported as a major health concern by the World Health Organization
[175], the UK and US governments through the launch of the global “combatting antimicro-
bial resistance” initiative. In this regard, due to memory effects and relationships among
the drug targets, recent experiments disproved the common idea that the overall effect of a
combination of drugs is less or equal to the sum of its ingredients. Therefore, the design of
an optimized multi-drug therapy would dramatically improve its positive effect.
In Chapter 4, to paraphrase Stan Ulam in his autobiography [77], we focused not only
on what computer science can do for biology, but also on how biology can inspire studies
in theoretical computer science. We showed how robust genetic interventions in cells can
be framed as optimal programs to be run in a molecular machine, in order to extend and
modify the behavior of cells and cell aggregates. For instance, programs can instruct cells to
make logic decisions according to environmental factors and current cell state. A program
embedded in a cell could allow its metabolic network to work with a specific user-imposed
aim, and therefore to perform computation.
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